Document:

exv10w2

 

Exhibit 10.2

EXECUTION COPY

9,250,000 Shares

COMMERCIAL VEHICLE GROUP, INC.

Common Stock

UNDERWRITING AGREEMENT

August 4, 2004

Credit Suisse First Boston LLC,

  As Representative of the Several Underwriters,

   NEleven Madison Avenue,

    New York, NY 10010-3629

Dear Sirs:

     1. Introductory. Commercial Vehicle Group, Inc., a Delaware corporation
(“Company”) proposes to issue and sell 3,125,000 shares of its Common Stock,
par value $0.01 per share (“Securities”), and the stockholders listed in
Schedule A hereto (“Selling Stockholders”) propose severally to sell an
aggregate of 6,125,000 outstanding shares of the Securities (such 9,250,000
shares of Securities being hereinafter referred to as the “Firm Securities”),
to the Underwriters (as defined below), for whom Credit Suisse First Boston LLC
is acting as representative (the “Representative”). The Company also proposes
to sell to the Underwriters, at the option of the Underwriters, an aggregate of
not more than 1,387,500 additional shares of its Securities as set forth below
(such 1,387,500 additional shares being hereinafter referred to as the
"Optional Securities”). The Firm Securities and the Optional Securities are
herein collectively called the “Offered Securities”. As part of the offering
contemplated by this Agreement, Credit Suisse First Boston LLC (the “Designated
Underwriter") has agreed to reserve out of the Firm Securities purchased by it
under this Agreement, up to 462,500 shares, for sale to the Company’s
directors, officers, employees and other parties associated with the Company
(collectively, “Participants"), as set forth in the Prospectus (as defined
herein) under the heading “Underwriting” (the “Directed Share Program"). The
Firm Securities to be sold by the Designated Underwriter pursuant to the
Directed Share Program (the “Directed Shares") will be sold by the Designated
Underwriter pursuant to this Agreement at the public offering price. Any
Directed Shares not subscribed for by the end of the business day on which this
Agreement is executed will be offered to the public by the Underwriters as set
forth in the Prospectus. The Company and the Selling Stockholders hereby agree
with the several Underwriters named in Schedule B hereto (“Underwriters”) as
follows:

 

 

     2. Representations and Warranties of the Company and the Selling
Stockholders. (a) The Company represents and warrants to, and agrees with,
the several Underwriters that:

     (i) A registration statement (No. 333-115708) relating to the
Offered Securities, including a form of prospectus, has been filed with
the Securities and Exchange Commission (“Commission”) and either (A) has
been declared effective under the Securities Act of 1933 (“Act”) and is
not proposed to be amended or (B) is proposed to be amended by amendment
or post-effective amendment. If such registration statement (the “initial
registration statement”) has been declared effective, either (A) an
additional registration statement (the “additional registration
statement”) relating to the Offered Securities may have been filed with
the Commission pursuant to Rule 462(b) (“Rule 462(b)”) under the Act and,
if so filed, has become effective upon filing pursuant to such Rule and
the Offered Securities all have been duly registered under the Act
pursuant to the initial registration statement and, if applicable, the
additional registration statement or (B) such an additional registration
statement is proposed to be filed with the Commission pursuant to Rule
462(b) and will become effective upon filing pursuant to such Rule and
upon such filing the Offered Securities will all have been duly
registered under the Act pursuant to the initial registration statement
and such additional registration statement. If the Company does not
propose to amend the initial registration statement or if an additional
registration statement has been filed and the Company does not propose to
amend it, and if any post-effective amendment to either such registration
statement has been filed with the Commission prior to the execution and
delivery of this Agreement, the most recent amendment (if any) to each
such registration statement has been declared effective by the Commission
or has become effective upon filing pursuant to Rule 462(c) (“Rule
462(c)”) under the Act or, in the case of the additional registration
statement, Rule 462(b). For purposes of this Agreement, “Effective Time”
with respect to the initial registration statement or, if filed prior to
the execution and delivery of this Agreement, the additional registration
statement means (A) if the Company has advised the Representative that it
does not propose to amend such registration statement, the date and time
as of which such registration statement, or the most recent
post-effective amendment thereto (if any) filed prior to the execution
and delivery of this Agreement, was declared effective by the Commission
or has become effective upon filing pursuant to Rule 462(c), or (B) if
the Company has advised the Representative that it proposes to file an
amendment or post-effective amendment to such registration statement, the
date and time as of which such registration statement, as amended by such
amendment or post-effective amendment, as the case may be, is declared
effective by the Commission. If an additional registration statement has
not been filed prior to the execution and delivery of this Agreement but
the Company has advised the Representative that it proposes to file one,
“Effective Time” with respect to such additional registration statement
means the date and time as of which such registration statement is filed
and becomes effective pursuant to Rule 462(b). “Effective Date” with
respect to the initial registration statement or the additional
registration statement (if any) means the date of the Effective Time
thereof. The initial registration statement, as amended at its Effective
Time, including all information contained in the additional registration
statement (if any) and deemed to be a part of the initial registration
statement as of the Effective Time of the additional registration
statement pursuant to the General Instructions of the Form on which it is
filed and including all information (if any) deemed to be a part of the
initial registration statement as of its Effective Time pursuant to Rule
430A(b) (“Rule 430A(b)”) under the Act, is hereinafter referred to as the
“Initial Registration Statement”. The additional registration statement,
as amended at its Effective Time,

2

 

including the contents of the initial registration statement
incorporated by reference therein and including all information (if any)
deemed to be a part of the additional registration statement as of its
Effective Time pursuant to Rule 430A(b), is hereinafter referred to as
the “Additional Registration Statement”. The Initial Registration
Statement and the Additional Registration Statement are hereinafter
referred to collectively as the “Registration Statements” and
individually as a “Registration Statement”. The form of prospectus
relating to the Offered Securities, as first filed with the Commission
pursuant to and in accordance with Rule 424(b) (“Rule 424(b)”) under the
Act or (if no such filing is required) as included in a Registration
Statement, is hereinafter referred to as the “Prospectus”. No document
has been or will be prepared or distributed in reliance on Rule 434 under
the Act.

     (ii) If the Effective Time of the Initial Registration Statement is
prior to the execution and delivery of this Agreement: (A) on the
Effective Date of the Initial Registration Statement, the Initial
Registration Statement conformed in all material respects to the
requirements of the Act and the rules and regulations of the Commission
(“Rules and Regulations”) and did not include any untrue statement of a
material fact or omit to state any material fact required to be stated
therein or necessary to make the statements therein not misleading, (B)
on the Effective Date of the Additional Registration Statement (if any),
each Registration Statement conformed or will conform, in all material
respects to the requirements of the Act and the Rules and Regulations and
did not include, or will not include, any untrue statement of a material
fact and did not omit, or will not omit, to state any material fact
required to be stated therein or necessary to make the statements therein
not misleading, and (C) on the date of this Agreement, the Initial
Registration Statement and, if the Effective Time of the Additional
Registration Statement is prior to the execution and delivery of this
Agreement, the Additional Registration Statement each conforms, and at
the time of filing of the Prospectus pursuant to Rule 424(b) or (if no
such filing is required) at the Effective Date of the Additional
Registration Statement in which the Prospectus is included, each
Registration Statement and the Prospectus will conform, in all material
respects to the requirements of the Act and the Rules and Regulations,
and neither of such documents includes, or will include, any untrue
statement of a material fact or omits, or will omit, to state any
material fact required to be stated therein or necessary to make the
statements therein not misleading. If the Effective Time of the Initial
Registration Statement is subsequent to the execution and delivery of
this Agreement: on the Effective Date of the Initial Registration
Statement, the Initial Registration Statement and the Prospectus will
conform in all material respects to the requirements of the Act and the
Rules and Regulations, neither of such documents will include any untrue
statement of a material fact or will omit to state any material fact
required to be stated therein or necessary to make the statements therein
not misleading, and no Additional Registration Statement has been or will
be filed. The two preceding sentences do not apply to statements in or
omissions from a Registration Statement or the Prospectus based upon
written information furnished to the Company by any Underwriter through
the Representative specifically for use therein, it being understood and
agreed that the only such information is that described as such in
Section 7(c) hereof, or relating to the Selling Stockholders, furnished
in writing to the Company by a Selling Stockholder specifically for use
therein.

3

 

     (iii) The Company has been duly incorporated and is an existing
corporation in good standing under the laws of the State of Delaware,
with power and authority (corporate and other) to own its properties and
conduct its business as described in the Prospectus; and the Company is
duly qualified to do business as a foreign corporation in good standing
in all other jurisdictions in which its ownership or lease of property or
the conduct of its business requires such qualification, except where the
failure to be so qualified would not have a material adverse effect on
the condition (financial or other), business, properties or results of
operations of the Company and its subsidiaries, taken as a whole (a
“Material Adverse Effect”).

     (iv) Each subsidiary of the Company has been duly incorporated and
is an existing corporation in good standing under the laws of the
jurisdiction of its incorporation, with corporate power and authority to
own or lease its properties and conduct its business as described in the
Prospectus; and each subsidiary of the Company is duly qualified to do
business as a foreign corporation in good standing in all other
jurisdictions in which its ownership or lease of property or the conduct
of its business requires such qualification, except where the failure to
be so qualified would not have a Material Adverse Effect; all of the
issued and outstanding capital stock of each subsidiary of the Company
has been duly authorized and validly issued and is fully paid and
nonassessable; and the capital stock of each subsidiary owned by the
Company, directly or through subsidiaries, is owned free from liens,
encumbrances and defects (other than transfer restrictions imposed under
applicable securities laws).

     (v) The entities listed on Schedule C hereto are the only
subsidiaries of the Company.

     (vi) No subsidiary, other than the subsidiaries indicated as
“significant subsidiaries” on Schedule C hereto, as of December 31, 2003,
was a “significant subsidiary” within the meaning of Regulation S-X under
the Act.

     (vii) The Offered Securities and all other outstanding shares of
capital stock of the Company have been duly authorized and validly
issued, fully paid and nonassessable and conform in all material respects
to the description thereof contained in the Prospectus; and the
stockholders of the Company have no preemptive rights with respect to the
Securities.

     (viii) Except as disclosed in the Prospectus, there are no
contracts, agreements or understandings between the Company and any
person that would give rise to a valid claim against the Company or any
Underwriter for a brokerage commission, finder’s fee or other like
payment in connection with this offering.

     (ix) There are no contracts, agreements or understandings between
the Company and any person granting such person the right to require the
Company to file a registration statement under the Act with respect to
any securities of the Company owned or to be owned by such person or to
require the Company to include such securities in the securities
registered pursuant to a Registration Statement or in any securities
being

4

 

registered pursuant to any other registration statement filed by
the Company under the Act that have not otherwise been complied with or
waived.

     (x) The Securities have been approved for listing, subject to notice
of issuance, on The Nasdaq National Market.

     (xi) No consent, approval, authorization, or order of, or filing
with, any governmental agency or body or any court is required to be
obtained or made by the Company for the consummation of the transactions
contemplated by this Agreement in connection with the sale of the Offered
Securities, except such as have been obtained and made under the Act and
the Securities Exchange Act of 1934 (the “Exchange Act”), and such as may
be required under state securities laws or rules of the National
Association of Securities Dealers, Inc. (the “NASD”).

     (xii) The execution, delivery and performance of this Agreement, and
the consummation of the transactions herein contemplated will not result
in a breach or violation of any of the terms and provisions of, or
constitute a default under, (a) any statute, any rule, regulation or
order of any governmental agency or body or any court, domestic or
foreign, having jurisdiction over the Company or any subsidiary of the
Company or any of their properties, or (b) any agreement or instrument to
which the Company or any such subsidiary is a party or by which the
Company or any such subsidiary is bound or to which any of the properties
of the Company or any such subsidiary is subject, or (c) the charter or
by-laws of the Company or any such subsidiary, other than, in the case of
(a) and (b), conflicts or breaches that, individually or in the
aggregate, would not reasonably be expected to have a Material Adverse
Effect.

     (xiii) This Agreement has been duly authorized, executed and
delivered by the Company.

     (xiv) Except as disclosed in the Prospectus, the Company and its
subsidiaries have good and marketable title to all real properties and
all other properties and assets owned by them, in each case free from
liens, encumbrances and defects the enforcement of which would reasonably
be expected to have a Material Adverse Effect; and except as disclosed in
the Prospectus, the Company and its subsidiaries hold any leased real or
personal property under valid and enforceable leases with no exceptions
that would materially interfere with the use made or to be made thereof
by them and no material default has occurred or is continuing under any
material lease to which the Company or any of its subsidiaries is a
party.

     (xv) The Company and its subsidiaries possess adequate certificates,
authorizations or permits issued by appropriate governmental agencies or
bodies necessary to conduct the business now operated by them, except for
such certificates, authorizations or permits the absence of which,
individually or in the aggregate, would not have a Material Adverse
Effect and have not received any notice of proceedings relating to the
revocation or modification of any such certificate, authorization or
permit that, if determined adversely to the Company or any of its
subsidiaries, would individually or in the aggregate have a Material
Adverse Effect.

5

 

     (xvi) No labor dispute with the employees of the Company or any
subsidiary exists or, to the knowledge of the Company, is imminent that
would reasonably be expected to have a Material Adverse Effect.

     (xvii) The Company and its subsidiaries own, possess or can acquire
on reasonable terms, adequate trademarks, trade names and other rights to
inventions, know-how, patents, copyrights, confidential information and
other intellectual property (collectively, “intellectual property
rights”) necessary to conduct the business now operated by them, or
presently employed by them, and have not received any notice of
infringement of or conflict with asserted rights of others with respect
to any intellectual property rights that, if determined adversely to the
Company or any of its subsidiaries, which individually or in the
aggregate would reasonably be expected to have a Material Adverse Effect.

     (xviii) Except as disclosed in the Prospectus, neither the Company
nor any of its subsidiaries is in violation of any statute, any rule,
regulation, decision or order of any governmental agency or body or any
court, domestic or foreign, relating to the use, disposal or release of
hazardous or toxic substances or relating to the protection or
restoration of the environment or human exposure to hazardous or toxic
substances (collectively, “environmental laws”), owns or operates any
real property contaminated with any substance that is subject to any
environmental laws, is liable for any off-site disposal or contamination
pursuant to any environmental laws, or is subject to any claim relating
to any environmental laws, which violation, contamination, liability or
claim would individually or in the aggregate have a Material Adverse
Effect; and the Company is not aware of any pending investigation which
might lead to such a claim.

     (xix) Except as disclosed in the Prospectus, there are no pending
actions, suits or proceedings against or affecting the Company, any of
its subsidiaries or any of their respective properties that, if
determined adversely to the Company or any of its subsidiaries, would
individually or in the aggregate have a Material Adverse Effect, or would
materially and adversely affect the ability of the Company to perform its
obligations under this Agreement, or which are otherwise material in the
context of the sale of the Offered Securities; and, to the Company’s
knowledge, no such actions, suits or proceedings are threatened or
contemplated.

     (xx) The financial statements, together with related notes, included
in each Registration Statement and the Prospectus present fairly in all
material respects the financial position of the Company and its
consolidated subsidiaries as of the dates shown and their results of
operations and cash flows for the periods shown, and such financial
statements have been prepared in accordance with the generally accepted
accounting principles in the United States applied on a consistent basis;
and the schedules included in each Registration Statement present fairly
the information required to be stated therein.

     (xxi) Each of the Company and its consolidated subsidiaries maintain
a system of internal accounting controls sufficient to provide reasonable
assurance that (a) transactions are executed in accordance with
management’s general or specific

6

 

authorizations; (b) transactions are
recorded as necessary to permit preparation of financial statements in
conformity with generally accepted accounting principles and to maintain
asset accountability; (c) access to assets is permitted only in
accordance with management’s general or specific authorization; and (d)
the recorded accountability for
assets is compared with the existing assets at reasonable intervals
and appropriate action is taken with respect to any differences.

     (xxii) Except as disclosed in the Prospectus, since the date of the
latest audited financial statements included in the Prospectus there has
been no material adverse change, nor any development or event involving a
prospective material adverse change, in the condition (financial or
other), business, properties or results of operations of the Company and
its subsidiaries taken as a whole, and, except as disclosed in or
contemplated by the Prospectus, there has been no dividend or
distribution of any kind declared, paid or made by the Company on any
class of its capital stock.

     (xxiii) The Company is not and, after giving effect to the offering
and sale of the Offered Securities and the application of the proceeds
thereof as described in the Prospectus, will not be an “investment
company” as defined in the Investment Company Act of 1940, as amended.

     (xxiv) The Company has not taken, directly or indirectly, any action
designed to or that would constitute or that might reasonably be expected
to cause or result in, under the Exchange Act or otherwise, stabilization
or manipulation of the price of any security of the Company to facilitate
the sale or resale of the Securities.

     (xxv) Except as would not, individually or in the aggregate,
reasonably be expected to have a Material Adverse Effect, (A) The minimum
funding standard under Section 302 of the Employee Retirement Income
Security Act of 1974, as amended, and the regulations and published
interpretations thereunder (“ERISA”), has been satisfied by each “pension
plan” (as defined in Section 3(2) of ERISA) which has been established or
maintained by the Company and/or one or more of its subsidiaries, each
plan which is intended to be qualified under Section 401 of the Code is
so qualified; (B) each of the Company and its subsidiaries has fulfilled
its obligations, if any, under Section 515 of ERISA; (C) neither the
Company nor any of its subsidiaries maintains or is required to
contribute to a “welfare plan” (as defined in Section 3(1) of ERISA)
which provides retiree or other post-employment welfare benefits or
insurance coverage (other than “continuation coverage” (as defined in
Section 602 of ERISA)); (D) each pension plan and welfare plan
established or maintained by the Company and/or one or more of its
subsidiaries is in compliance with the currently applicable provisions of
ERISA and the Code; and (E) neither the Company nor any of its
subsidiaries has incurred or could reasonably be expected to incur any
withdrawal liability under Section 4201 of ERISA, any liability under
Section 4062, 4063, or 4064 of ERISA, or any other liability under Title
IV of ERISA.

     (xxvi) There is and has been no failure on the part of the Company
and any of the Company’s directors or officers, in their capacities as
such, to comply with any provision of the Sarbanes-Oxley Act of 2002 and
the rules and regulations promulgated

7

 

in connection therewith (the
“Sarbanes-Oxley Act”), including Section 402 related to loans and
Sections 302 and 906 related to certifications, to the extent such
sections are applicable.

     (xxvii) Furthermore, the Company represents and warrants to the
Underwriters that (i) the Registration Statement, the Prospectus and any
preliminary prospectus comply in all material respects, and any further
amendments or supplements thereto will comply in all material respects,
with any applicable laws or regulations of foreign jurisdictions in which
the Prospectus or any preliminary prospectus, as amended or supplemented,
if applicable, are distributed in connection with the Directed Share
Program, and that (ii) no authorization, approval, consent, license,
order, registration or qualification of or with any government,
governmental instrumentality or court, other than such as have been
obtained, is necessary under the securities law and regulations of
foreign jurisdictions in which the Directed Shares are offered outside
the United States.

     (xxviii) The Company has not offered, or caused the Underwriters to
offer, any Offered Securities to any person pursuant to the Directed
Share Program with the specific intent to unlawfully influence (i) a
customer or supplier of the Company to alter the customer’s or supplier’s
level or type of business with the Company or (ii) a trade journalist or
publication to write or publish favorable information about the Company
or its products.

     (b) Each Selling Stockholder severally represents and warrants to, and
agrees with, the several Underwriters that:

     (i) Such Selling Stockholder has and on each Closing Date
hereinafter mentioned will have valid and unencumbered title to the
Offered Securities to be delivered by such Selling Stockholder on such
Closing Date and full right, power and authority to enter into this
Agreement and to sell, assign, transfer and deliver the Offered
Securities to be delivered by such Selling Stockholder on such Closing
Date hereunder; and upon the delivery of and payment for the Offered
Securities to be sold by such Selling Stockholder on each Closing Date
hereunder the several Underwriters will acquire valid and unencumbered
title to the Offered Securities to be delivered by such Selling
Stockholder on such Closing Date.

     (ii) Such Selling Stockholder has not taken, directly or indirectly,
any action designed to or that would constitute or that might reasonably
be expected to cause or result in, under the Exchange Act or otherwise,
stabilization or manipulation of the price of any security of the Company
to facilitate the sale or resale of the Securities.

     (iii) No consent, approval, authorization or order of, or filing
with, any governmental agency or body or any court is required to be
obtained or made by such Selling Stockholder for the consummation of the
transactions contemplated by this Agreement in connection with the sale
of the Offered Securities sold by such Selling Stockholder, except such
as have been obtained and made under the Act and the Exchange Act and
such as may be required under state securities laws or the rules of the
NASD.

8

 

     (iv) This Agreement has been duly authorized, executed and delivered
by or on behalf of such Selling Stockholder.

     (v) If the Effective Time of the Initial Registration Statement is
prior to the execution and delivery of this Agreement: (A) on the
Effective Date of the Initial Registration Statement, the Initial
Registration Statement did not include any untrue statement of a material
fact or omit to state any material fact required to be stated therein or
necessary to make the statements therein not misleading, (B) on the
Effective Date of the Additional Registration Statement (if any), each
Registration Statement did not include, or will not include, any untrue
statement of a material fact and did not omit, or will not omit, to state
any material fact required to be stated therein or necessary to make the
statements therein not misleading, and (C) on the date of this Agreement,
the Initial Registration Statement and, if the Effective Time of the
Additional Registration Statement is prior to the execution and delivery
of this Agreement, the Additional Registration Statement, and at the time
of filing of the Prospectus pursuant to Rule 424(b) or (if no such filing
is required) at the Effective Date of the Additional Registration
Statement in which the Prospectus is included, each Registration
Statement and the Prospectus did not include, or will not include, any
untrue statement of a material fact or omits, or will omit, to state any
material fact required to be stated therein or necessary to make the
statements therein not misleading. If the Effective Time of the Initial
Registration Statement is subsequent to the execution and delivery of
this Agreement: on the Effective Date of the Initial Registration
Statement, the Initial Registration Statement and the Prospectus will not
include any untrue statement of a material fact or will omit to state any
material fact required to be stated therein or necessary to make the
statements therein not misleading. This paragraph 2(b)(v) applies only
to statements in or omissions from a Registration Statement or the
Prospectus that relate to such Selling Stockholder and are based upon
written information furnished to the Company by such Selling Stockholder
specifically for use therein.

     (vi) The sale of the Offered Securities by such Selling Stockholder
pursuant hereto is not prompted by any information concerning the Company
or any of its subsidiaries which is not set forth in the Prospectus or
any supplement thereto.

     (vii) Except as disclosed in the Prospectus, there are no contracts,
agreements or understandings between such Selling Stockholder and any
person that would give rise to a valid claim against such Selling
Stockholder or any Underwriter for a brokerage commission, finder’s fee
or other like payment in connection with this offering.

     3. Purchase, Sale and Delivery of Offered Securities. On the basis of the
representations, warranties and agreements herein contained, but subject to the
terms and conditions herein set forth, the Company and each Selling Stockholder
agree, severally and not jointly, to sell to each Underwriter, and each
Underwriter agrees, severally and not jointly, to purchase from the Company and
each Selling Stockholder, at a purchase price of $12.1225 per share, that
number of Firm Securities (rounded up or down, as determined by Credit Suisse
First Boston LLC (“CSFB”) in its discretion, in order to avoid fractions)
obtained by multiplying 3,125,000 Firm Securities in the case of the Company
and the number of Firm Securities set forth opposite the name of such Selling
Stockholder in Schedule A hereto, in the case of a Selling Stockholder, in each
case by a fraction

9

 

the numerator of which is the number of Firm Securities set
forth opposite the name of such Underwriter in Schedule B hereto and the
denominator of which is the total number of Firm Securities.

     Certificates in negotiable form for the Offered Securities to be sold by
the Selling Stockholders listed on Schedule D-1 (the “Custodial Selling
Stockholders”) hereunder have been placed in custody, for delivery under this
Agreement, under Custody Agreements (the “Custody Agreements”) made with Hidden
Creek Industries, as custodian (“Custodian”). The Selling Stockholders other
than the Custodial Selling Stockholders (the “Onex Selling Stockholders”) have
entered into an irrevocable power of attorney appointing Onex American Holdings
II LLC as attorney-in-fact for each Onex Selling Stockholder, with full power
and authority to act in the name of and for and on behalf of each such Onex
Selling Stockholder with respect to all matters arising in connection with the
sale of Securities by each such Onex Selling Stockholder.

     Each Custodial Selling Stockholder agrees that the shares represented by
the certificates held in custody for the Custodial Selling Stockholders under
such Custody Agreements are subject to the interests of the Underwriters
hereunder, that the arrangements made by the Custodial Selling Stockholders for
such custody are to that extent irrevocable, and that the obligations of the
Custodial Selling Stockholders hereunder shall not be terminated by operation
of law, whether by the death of any individual Custodial Selling Stockholder or
the occurrence of any other event, or in the case of a trust, by the death of
any trustee or trustees or the termination of such trust. If any individual
Custodial Selling Stockholder or any such trustee or trustees should die, or if
any other such event should occur, or if any of such trusts should terminate,
before the delivery of the Offered Securities hereunder, certificates for such
Offered Securities shall be delivered by the Custodian in accordance with the
terms and conditions of this Agreement as if such death or other event or
termination had not occurred, regardless of whether or not the Custodian shall
have received notice of such death or other event or termination.

     The Company, the Custodian and the Onex Selling Stockholders will deliver
the Firm Securities to the Representative for the accounts of the Underwriters,
against payment of the purchase price in Federal (same day) funds by official
bank check or checks or wire transfer to an account at a bank acceptable to
CSFB drawn to the order of the Company in the case of 3,125,000 shares of Firm
Securities, the Custodian in the case of 2,300,297 shares of Firm Securities
and Onex American Holdings II LLC in the case of 3,824,703 shares of Firm
Securities, at the office of Cravath, Swaine & Moore LLP, at 10:00 A.M., New
York time, on August 10, 2004, or at such other time not later than seven full
business days thereafter as CSFB and the Company determine, such time being
herein referred to as the “First Closing Date”. For purposes of Rule 15c6-1
under the Exchange Act, the First Closing Date (if later than the otherwise
applicable settlement date) shall be the settlement date for payment of funds
and delivery of securities for all the Offered Securities sold pursuant to the
offering. The certificates for the Firm Securities so to be delivered will be
in definitive form, in such denominations and registered in such names as CSFB
requests and will be made available for checking and packaging at the office of
Cravath, Swaine & Moore LLP at least 24 hours prior to the First Closing Date.

     In addition, upon written notice from CSFB given to the Company from time
to time (not to exceed three times) not more than 30 days subsequent to the
date of the Prospectus, the Underwriters may purchase all or less than all of
the Optional Securities at the purchase price per

10

 

Security to be paid for the
Firm Securities. The Company agrees to sell to the Underwriters the number of
Optional Securities specified in such notice and the Underwriters agree,
severally and not jointly, to purchase such Optional Securities. Such Optional
Securities shall be purchased from the Company for the account of each
Underwriter in the same proportion as the number of Firm Securities set forth
opposite such Underwriter’s name bears to the total number of Firm Securities
(subject to adjustment by CSFB to eliminate fractions) and may be
purchased by the Underwriters only for the purpose of covering over-allotments
made in connection with the sale of the Firm Securities. No Optional Securities
shall be sold or delivered unless the Firm Securities previously have been, or
simultaneously are, sold and delivered. The right to purchase the Optional
Securities or any portion thereof may be exercised from time to time (not to
exceed three times) and to the extent not previously exercised may be
surrendered and terminated at any time upon notice by CSFB to the Company and
the Selling Stockholders.

     Each time for the delivery of and payment for the Optional Securities,
being herein referred to as an “Optional Closing Date”, which may be the First
Closing Date (the First Closing Date and each Optional Closing Date, if any,
being sometimes referred to as a “Closing Date”), shall be determined by CSFB
but shall be not later than five full business days after written notice of
election to purchase Optional Securities is given. The Company will deliver
the Optional Securities being purchased from the Company on each Optional
Closing Date to the Representative for the accounts of the several
Underwriters, against payment of the purchase price therefor in Federal (same
day) funds by official bank check or checks or wire transfer to an account at a
bank acceptable to CSFB drawn to the order of the Company with respect to the
Optional Securities being so purchased on such Optional Closing Date, at the
office of Cravath, Swaine & Moore LLP. The certificates for the Optional
Securities being purchased on each Optional Closing Date will be in definitive
form, in such denominations and registered in such names as CSFB requests upon
reasonable notice prior to such Optional Closing Date and will be made
available for checking and packaging at the office of Cravath, Swaine & Moore
LLP at a reasonable time in advance of such Optional Closing Date.

     4. Offering by Underwriters. It is understood that the several
Underwriters propose to offer the Offered Securities for sale to the public as
set forth in the Prospectus.

     5. Certain Agreements of the Company and the Selling Stockholders. The
Company agrees with the several Underwriters and the Selling Stockholders that:

     (a) If the Effective Time of the Initial Registration Statement is prior
to the execution and delivery of this Agreement, the Company will file the
Prospectus with the Commission pursuant to and in accordance with subparagraph
(1) (or, if applicable and if consented to by CSFB, subparagraph (4)) of Rule
424(b) not later than the earlier of (A) the second business day following the
execution and delivery of this Agreement or (B) the fifteenth business day
after the Effective Date of the Initial Registration Statement.

     The Company will advise CSFB promptly of any such filing pursuant to Rule
424(b). If the Effective Time of the Initial Registration Statement is prior to
the execution and delivery of this Agreement and an additional registration
statement is necessary to register a portion of the Offered Securities under
the Act but the Effective Time thereof has not occurred as of such execution
and delivery, the Company will file the additional registration statement or,
if filed, will file a post-

11

 

effective amendment thereto with the Commission
pursuant to and in accordance with Rule 462(b) on or prior to 10:00 P.M., New
York time, on the date of this Agreement or, if earlier, on or prior to the
time the Prospectus is printed and distributed to any Underwriter, or will make
such filing at such later date as shall have been consented to by CSFB.

     (b) The Company will advise CSFB promptly of any proposal to amend or
supplement the initial or any additional registration statement as filed or the
related prospectus or the Initial Registration Statement, the Additional
Registration Statement (if any) or the Prospectus and will not effect such
amendment or supplementation without CSFB’s consent; and the Company will also
advise CSFB promptly of the effectiveness of each Registration Statement (if
its Effective Time is subsequent to the execution and delivery of this
Agreement) and of any amendment or supplementation of a Registration Statement
or the Prospectus and of the institution by the Commission of any stop order
proceedings in respect of a Registration Statement and will use its reasonable
best efforts to prevent the issuance of any such stop order and to obtain as
soon as possible its lifting, if issued.

     (c) If, at any time when a prospectus relating to the Offered Securities
is required to be delivered under the Act in connection with sales by any
Underwriter or dealer, any event occurs as a result of which the Prospectus as
then amended or supplemented would include an untrue statement of a material
fact or omit to state any material fact necessary to make the statements
therein, in the light of the circumstances under which they were made, not
misleading, or if it is necessary at any time to amend the Prospectus to comply
with the Act, the Company will promptly notify CSFB of such event and will
promptly prepare and file with the Commission, at its own expense, an amendment
or supplement which will correct such statement or omission or an amendment
which will effect such compliance. Neither CSFB’s consent to, nor the
Underwriters’ delivery of, any such amendment or supplement shall constitute a
waiver of any of the conditions set forth in Section 6.

     (d) As soon as practicable, but not later than the Availability Date (as
defined below), the Company will make generally available to its
securityholders an earnings statement covering a period of at least 12 months
beginning after the Effective Date of the Initial Registration Statement (or,
if later, the Effective Date of the Additional Registration Statement) which
will satisfy the provisions of Section 11(a) of the Act. For the purpose of the
preceding sentence, “Availability Date” means the 45th day after the end of the
fourth fiscal quarter following the fiscal quarter that includes such Effective
Date, except that, if such fourth fiscal quarter is the last quarter of the
Company’s fiscal year, “Availability Date” means the 90th day after the end of
such fourth fiscal quarter.

     (e) The Company will furnish to the Representative copies of each
Registration Statement (four of which will be signed and one of which will
include all exhibits), each related preliminary prospectus, and, so long as a
prospectus relating to the Offered Securities is required to be delivered under
the Act in connection with sales by any Underwriter or dealer, the Prospectus
and all amendments and supplements to such documents, in each case in such
quantities as CSFB reasonably requests. The Prospectus shall be so furnished on
or prior to 3:00 P.M., New York time, on the business day following the later
of the execution and delivery of this Agreement or the Effective Time of the
Initial Registration Statement. All other such

12

 

documents shall be so furnished
as soon as available. The Company and the Selling Stockholders will pay the
expenses of printing and distributing to the Underwriters all such documents.

     (f) The Company will arrange for the qualification of the Offered
Securities for sale under the laws of such jurisdictions as CSFB designates and
will continue such qualifications in effect so long as required for the
distribution; provided, however, that the Company shall not be
required to qualify to do business, consent to service of process or
become subject to taxation in any jurisdiction in which it has not already done
so.

     (g) During the period of three years hereafter, the Company will furnish
to the Representative and, upon request, to each of the other Underwriters, as
soon as practicable after the end of each fiscal year, a copy of its annual
report to stockholders for such year; and the Company will furnish to the
Representative (i) as soon as available, a copy of each report and any
definitive proxy statement of the Company filed with the Commission under the
Exchange Act or mailed to stockholders, and (ii) from time to time, such other
information concerning the Company as CSFB may reasonably request.

     (h) For the period specified below (the “Lock-Up Period”), the Company
will not offer, sell, contract to sell, pledge or otherwise dispose of,
directly or indirectly, or file with the Commission a registration statement
under the Act relating to, any additional shares of its Securities or
securities convertible into or exchangeable or exercisable for any shares of
its Securities, or publicly disclose the intention to make any such offer,
sale, pledge, disposition or filing, without the prior written consent of CSFB.
The initial Lock-Up Period will commence on the date of this Agreement and
continue for 180 days after the public offering date set forth on the final

prospectus used to sell the Securities (the “Public Offering Date”) or such
earlier date that CSFB consents to in writing; provided, however, that if (1)
during the last 17 days of the initial Lock-Up Period, the Company releases
earnings results or material news or a material event relating to the Company
occurs or (2) prior to the expiration of the initial Lock-Up Period, the
Company announces that it will release earnings results during the 16-day
period beginning on the last day of the initial Lock-Up Period, then in each
case, the Lock-Up Period will be extended until the expiration of the 18-day
period beginning on the date of release of the earnings results or the
occurrence of the material news or material event, as applicable, unless CSFB
waives, in writing, such extension. Any Securities received upon exercise of
options granted to the undersigned will also be subject to this paragraph 5(h).
Any Securities acquired in the open market or in the Directed Share Program,
and any Securities sold in the Offering pursuant to this Agreement, will not be
subject to this paragraph 5(h). A transfer of Securities to a family member,
trust or controlled affiliate may be made, provided the transferee agrees to be
bound in writing by the terms of this paragraph 5(h). In addition, the Company
may transfer Securities or securities convertible into or exchangeable or
exercisable for Securities pursuant to a sale of 100% of the outstanding
Securities (including, without limitation, in connection with a tender offer
for such Securities or by way of merger of the Company with another person) to
a third party or group of third parties that are not affiliates of the Company,
provided that the third party or group of third parties agrees in writing to be
bound by the restrictions set forth herein until such time as such third party
or group of third parties has acquired 100% of the outstanding Securities of
the Company.

13

 

     (i) The Company and each Selling Stockholder agree with the several
Underwriters that the Company and such Selling Stockholder will pay all
expenses incident to the performance of the obligations of the Company and such
Selling Stockholder, as the case may be, under this Agreement; the Company will
pay for any filing fees and other expenses (including fees and disbursements of
counsel) in connection with qualification of the Offered Securities for sale
under the laws of such jurisdictions as CSFB designates and the printing of
memoranda relating thereto, for the filing fee incident to the review by the
NASD of the Offered Securities, for any travel expenses of the Company’s
officers and employees and any other expenses of the
Company in connection with attending or hosting meetings with prospective
purchasers of the Offered Securities and for expenses incurred in distributing
preliminary prospectuses and the Prospectus (including any amendments and
supplements thereto) to the Underwriters and each Selling Stockholder will pay
for any transfer taxes on the sale by such Selling Stockholder of the Offered
Securities to the Underwriters. Nothing in this paragraph 5(i) amends or
otherwise alters any existing agreement among the Company and the Selling
Stockholders with respect to responsibilities for expenses in connection with
the registration of the Offered Securities.

     (j) In connection with the Directed Share Program, the Company will ensure
that the Directed Shares will be restricted to the extent required by the NASD
or the NASD rules from sale, transfer, assignment, pledge or hypothecation for
a period of three months following the date of the effectiveness of the
Registration Statement. The Designated Underwriter will notify the Company as

to which Participants will need to be so restricted. The Company will direct
the transfer agent to place stop transfer restrictions upon such securities for
such period of time.

     (k) The Company will pay all fees and disbursements of counsel incurred by
the Underwriters in connection with the Directed Share Program and stamp
duties, similar taxes or duties or other taxes, if any, incurred by the
underwriters in connection with the Directed Share Program.

     Furthermore, the Company covenants with the Underwriters that the Company
will comply with all applicable securities and other applicable laws, rules and
regulations in each foreign jurisdiction in which the Directed Shares are
offered in connection with the Directed Share Program.

     6. Conditions of the Obligations of the Underwriters. The obligations of
the several Underwriters to purchase and pay for the Firm Securities on the
First Closing Date and the Optional Securities to be purchased on each Optional
Closing Date will be subject to the accuracy of the representations and
warranties on the part of the Company and the Selling Stockholders herein, to
the accuracy in all material respects of the statements of Company officers
made pursuant to the provisions hereof, to the performance in all material
respects by the Company and the Selling Stockholders of their obligations
hereunder and to the following additional conditions precedent:

     (a) The Representative shall have received a letter, dated the date of
delivery thereof (which, if the Effective Time of the Initial Registration
Statement is prior to the execution and delivery of this Agreement, shall be on
or prior to the date of this Agreement or, if the Effective Time of the Initial
Registration Statement is subsequent to the execution and delivery of this
Agreement, shall be prior to the filing of the amendment or post-effective
amendment to the registration statement to be filed shortly prior to such
Effective Time), of Deloitte & Touche LLP

14

 

confirming that they are independent
certified public accountants within the meaning of the Act and the applicable
published Rules and Regulations thereunder and stating to the effect that:

     (i) in their opinion the financial statements and schedules examined
by them and included in the Registration Statements comply as to form in
all material respects with the applicable accounting requirements of the
Act and the related published Rules and Regulations;

     (ii) they have performed the procedures specified by the American
Institute of Certified Public Accountants for a review of interim
financial information as described in Statement of Auditing Standards No.
100, Interim Financial Information, on the unaudited financial statements
included in the Registration Statements;

     (iii) on the basis of the review referred to in clause (ii) above, a
reading of the latest available interim financial statements of the
Company, inquiries of officials of the Company who have responsibility
for financial and accounting matters and other specified procedures,
nothing came to their attention that caused them to believe that:

     (A) the unaudited financial statements included in the
Registration Statements do not comply as to form in all material
respects with the applicable accounting requirements of the Act
and the related published Rules and Regulations or any material
modifications should be made to such unaudited financial
statements for them to be in conformity with generally accepted
accounting principles;

     (B) at the date of the latest available balance sheet read by
such accountants, or at a subsequent specified date not more than
three business days prior to the date of this Agreement, there was
any change in the capital stock or any increase in total debt of
the Company and its consolidated subsidiaries or, at the date of
the latest available balance sheet read by such accountants, there
was any decrease in consolidated total assets, as compared with
amounts shown on the latest balance sheet included in the
Prospectus; or

     (C) for the period from the closing date of the latest income
statement included in the Prospectus to the closing date of the
latest available income statement read by such accountants, or to
a subsequent specified date not more than three business days
prior to the date of this Agreement, there were any decreases, as
compared with the corresponding period of the previous year, in
consolidated revenue or net operating income in the total or per
share amounts of consolidated net income;

     except in all cases set forth in clauses (B) and (C) above for changes,
increases or decreases which the Prospectus discloses have occurred or
may occur or which are described in such letter; and

     (iv) they have compared specified dollar amounts (or percentages
derived from such dollar amounts) and other financial information
contained in the Registration

15

 

Statements (in each case to the extent that
such dollar amounts, percentages and other financial information are
derived from the general accounting records of the Company and its
subsidiaries subject to the internal controls of the Company’s accounting
system or are derived directly from such records by analysis or
computation) with the results obtained from inquiries, a reading of such
general accounting records and other procedures specified in such letter
and have found such dollar amounts, percentages and other financial
information to be in agreement with such results, except as otherwise
specified in such letter.

For purposes of this subsection, (i) if the Effective Time of the Initial
Registration Statements is subsequent to the execution and delivery of this
Agreement, “Registration Statements” shall mean the initial registration
statement as proposed to be amended by the amendment or post-effective
amendment to be filed shortly prior to its Effective Time, (ii) if the
Effective Time of the Initial Registration Statements is prior to the execution
and delivery of this Agreement but the Effective Time of the Additional
Registration Statement is subsequent to such execution and delivery,
“Registration Statements” shall mean the Initial Registration Statement and the
Additional Registration Statement as proposed to be filed or as proposed to be
amended by the post-effective amendment to be filed shortly prior to its
Effective Time, and (iii) “Prospectus” shall mean the prospectus included in
the Registration Statements.

     (b) If the Effective Time of the Initial Registration Statement is not
prior to the execution and delivery of this Agreement, such Effective Time
shall have occurred not later than 10:00 P.M., New York time, on the date of
this Agreement or such later date as shall have been consented to by CSFB. If
the Effective Time of the Additional Registration Statement (if any) is not
prior to the execution and delivery of this Agreement, such Effective Time
shall have occurred not later than 10:00 P.M., New York time, on the date of
this Agreement or, if earlier, the time the Prospectus is printed and
distributed to any Underwriter, or shall have occurred at such later date as
shall have been consented to by CSFB. If the Effective Time of the Initial
Registration Statement is prior to the execution and delivery of this
Agreement, the Prospectus shall have been filed with the Commission in
accordance with the Rules and Regulations and Section 5(a) of this Agreement.
Prior to such Closing Date, no stop order suspending the effectiveness of a
Registration Statement shall have been issued and no proceedings for that
purpose shall have been instituted or, to the knowledge of any Selling
Stockholder, the Company or the Representative, shall be contemplated by the
Commission.

     (c) Subsequent to the execution and delivery of this Agreement, there
shall not have occurred (i) any change, or any development or event involving a
prospective change, in the condition (financial or other), business, properties
or results of operations of the Company and its subsidiaries taken as one
enterprise which, in the judgment of a majority in interest of the Underwriters
including the Representative, is material and adverse and makes it impractical
or inadvisable to proceed with completion of the public offering or the sale of
and payment for the Offered Securities; (ii) any downgrading in the rating of
any debt securities of the Company by any “nationally recognized statistical
rating organization” (as defined for purposes of Rule 436(g) under the Act), or
any public announcement that any such organization has under surveillance or
review its rating of any debt securities of the Company (other than an
announcement with positive implications of a possible upgrading, and no
implication of a possible downgrading, of such rating); (iii) any change in
U.S. or international financial, political

16

 

or economic conditions or currency
exchange rates or exchange controls as would, in the judgment of a majority in
interest of the Underwriters including the Representative, be likely to
prejudice materially the success of the proposed issue, sale or distribution of
the Offered Securities, whether in the primary market or in respect of dealings
in the secondary market; (iv) any material suspension or material limitation of
trading in securities generally on the New York Stock Exchange or any setting
of minimum prices for trading on such exchange; (v) any suspension of trading
of any securities of the Company on any exchange or in the over-the-counter
market; (vi) any banking moratorium declared by U.S. Federal or New York
authorities; (vii) any major disruption of settlements of securities or
clearance services in the United States or (viii) any attack on, outbreak or
escalation of hostilities or act of terrorism involving the
United States, any declaration of war by Congress or any other national or
international calamity or emergency if, in the judgment of a majority in
interest of the Underwriters including the Representative, the effect of any
such attack, outbreak, escalation, act, declaration, calamity or emergency
makes it impractical or inadvisable to proceed with completion of the public
offering or the sale of and payment for the Offered Securities.

     (d) The Representative shall have received an opinion, dated such Closing
Date, of Kirkland & Ellis LLP, counsel for the Company, substantially in the
form of Exhibit A hereto.

     (e) If such Closing Date is the First Closing Date, the Representative
shall have received an opinion, dated such Closing Date, of Kirkland & Ellis
LLP, counsel for the Selling Stockholders listed on Schedule D-2, substantially
in the form of Exhibit B hereto.

     (f) If such Closing Date is the First Closing Date, the Representative
shall have received an opinion, dated such Closing Date, of Kaye Scholer LLP,
counsel for the Selling Stockholders listed on Schedule D-3, substantially in
the form of Exhibit C hereto.

     (g) If such Closing Date is the First Closing Date, the Representative
shall have received an opinion, dated such Closing Date, of Drinker Biddle &
Reath LLP, counsel for ASC Incorporated, substantially in the form of Exhibit D
hereto.

     (h) The Representative shall have received from Cravath, Swaine & Moore
LLP, counsel for the Underwriters, such opinion or opinions, dated such Closing
Date, with respect to the incorporation of the Company, the validity of the
Offered Securities delivered on such Closing Date, the Registration Statements,
the Prospectus and other related matters as the Representative may require, and
the Selling Stockholders and the Company shall have furnished to such counsel
such documents as they request for the purpose of enabling them to pass upon
such matters.

     (i) The Representative shall have received a certificate, dated such
Closing Date, of the President or any Vice President and a principal financial
or accounting officer of the Company in which such officers, to the best of
their knowledge after reasonable investigation, shall state that: the
representations and warranties of the Company in this Agreement are true and
correct; the Company has complied in all material respects with all agreements
and satisfied all conditions on its part to be performed or satisfied hereunder
at or prior to such Closing Date; no stop order suspending the effectiveness of
any Registration Statement has been issued and no proceedings for that purpose
have been instituted or are contemplated by the Commission; the Additional
Registration Statement (if any) satisfying the requirements of subparagraphs
(1) and (3) of Rule

17

 

462(b) was filed pursuant to Rule 462(b), including payment
of the applicable filing fee in accordance with Rule 111(a) or (b) under the
Act, prior to the time the Prospectus was printed and distributed to any
Underwriter; and, subsequent to the date of the most recent financial
statements in the Prospectus, there has been no material adverse change, nor
any development or event involving a prospective material adverse change, in
the condition (financial or other), business, properties or results of
operations of the Company and its subsidiaries taken as a whole except as set
forth in the Prospectus or as described in such certificate.

     (j) The Representative shall have received a letter, dated such Closing
Date, of Deloitte & Touche LLP which meets the requirements of subsection (a)
of this Section, except that the
specified date referred to in such subsection will be a date not more than
three days prior to such Closing Date for the purposes of this subsection.

     (k) The Representative shall have received a certificate, dated such
Closing Date, from Chad M. Utrup, Chief Financial Officer of the Company,
substantially in the form of Exhibit E.

     (l) On or prior to the date of this Agreement, the Representative shall
have received lock-up letters from each of the executive officers and directors
of the Company and each existing stockholder of the Company substantially in
the form of Exhibit F.

     (m) The Custodian will deliver to CSFB a letter stating that they will
deliver to each Custodial Selling Stockholder a United States Treasury
Department Form 1099 (or other applicable form or statement specified by the
United States Treasury Department regulations in lieu thereof) on or before
January 31 of the year following the date of this Agreement.

The Selling Stockholders and the Company will furnish the Representative with
such conformed copies of such opinions, certificates, letters and documents as
the Representative reasonably requests. CSFB may in its sole discretion waive
on behalf of the Underwriters compliance with any conditions to the obligations
of the Underwriters hereunder, whether in respect of an Optional Closing Date
or otherwise.

     7. Indemnification and Contribution. (a) The Company will indemnify and
hold harmless each Underwriter, its partners, members, directors and officers
and each person, if any, who controls such Underwriter within the meaning of
Section 15 of the Act or Section 20 of the Exchange Act, against any losses,
claims, damages or liabilities, joint or several, to which such Underwriter may
become subject, under the Act or otherwise, insofar as such losses, claims,
damages or liabilities (or actions in respect thereof) arise out of or are
based upon any untrue statement or alleged untrue statement of any material
fact contained in any Registration Statement, the Prospectus, or any amendment
or supplement thereto, or any related preliminary prospectus, or arise out of
or are based upon the omission or alleged omission to state therein a material
fact required to be stated therein or necessary to make the statements therein
not misleading, and will reimburse each Underwriter for any legal or other
expenses reasonably incurred by such Underwriter in connection with
investigating or defending any such loss, claim, damage, liability or action as
such expenses are incurred; provided, however, that the Company will not be
liable in any such case to the extent that any such loss, claim, damage or
liability arises out of or is based upon an untrue statement or alleged untrue
statement in or omission or alleged omission from any of such documents in
reliance upon and in conformity with (a) written information furnished to the

18

 

Company by any Underwriter through the Representative specifically for use
therein or (b) written information furnished to the Company by the Selling
Stockholders specifically for use therein, it being understood and agreed that
the only such information furnished by any Underwriter consists of the
information described as such in subsection (c) below.

     The Company agrees to indemnify and hold harmless the Designated
Underwriter and each person, if any, who controls the Designated Underwriter
within the meaning of either Section 15 of the Securities Act or Section 20 of
the Exchange Act (the “Designated Entities”), from and against any and all
losses, claims, damages and liabilities (including, without limitation, any
legal or other expenses reasonably incurred in connection with defending or
investigating any such action or claim) (i) caused by any untrue statement or
alleged untrue statement of a material fact contained in
any material prepared by or with the consent of the Company for
distribution to Participants in connection with the Directed Share Program or
caused by any omission or alleged omission to state therein a material fact
required to be stated therein or necessary to make the statements therein not
misleading; (ii) caused by the failure of any Participant to pay for and accept
delivery of Directed Shares that the Participant agreed to purchase; or (iii)
related to, arising out of, or in connection with the Directed Share Program,
other than losses, claims, damages or liabilities (or expenses relating
thereto) that are finally judicially determined to have resulted from the bad
faith or gross negligence of the Designated Entities.

     (b) Each Selling Stockholder, severally and not jointly will indemnify and
hold harmless each Underwriter, its partners, members, directors and officers
and each person who controls such Underwriter within the meaning of Section 15
of the Act or Section 20 of the Exchange Act, against any losses, claims,
damages or liabilities, joint or several, to which such Underwriter may become
subject, under the Act or otherwise, insofar as such losses, claims, damages or
liabilities (or actions in respect thereof) arise out of or are based upon any
untrue statement or alleged untrue statement of any material fact contained in
any Registration Statement, the Prospectus, or any amendment or supplement
thereto, or any related preliminary prospectus, or arise out of or are based
upon the omission or alleged omission to state therein a material fact required
to be stated therein or necessary to make the statements therein not
misleading, in each case to the extent, but only to the extent, that such
untrue statement or alleged untrue statement or omission or alleged omission
was made in reliance upon and in conformity with written information furnished
to the Company by such Selling Stockholder specifically for use therein, and
will reimburse each Underwriter for any legal or other expenses reasonably
incurred by such Underwriter in connection with investigating or defending any
such loss, claim, damage, liability or action as such expenses are incurred.

     (c) Each Underwriter will severally and not jointly indemnify and hold
harmless the Company, its directors and officers and each person, if any, who
controls the Company within the meaning of Section 15 of the Act or Section 20
of the Exchange Act, and each Selling Stockholder against any losses, claims,
damages or liabilities to which the Company or such Selling Stockholder may
become subject, under the Act or otherwise, insofar as such losses, claims,
damages or liabilities (or actions in respect thereof) arise out of or are
based upon any untrue statement or alleged untrue statement of any material
fact contained in any Registration Statement, the Prospectus, or any amendment
or supplement thereto, or any related preliminary prospectus, or arise out of
or are based upon the omission or the alleged omission to state therein a
material fact required to be stated therein or necessary to make the statements
therein not

19

 

misleading, in each case to the extent, but only to the extent,
that such untrue statement or alleged untrue statement or omission or alleged
omission was made in reliance upon and in conformity with written information
furnished to the Company by such Underwriter through the Representative
specifically for use therein, and will reimburse any legal or other expenses
reasonably incurred by the Company and each Selling Stockholder in connection
with investigating or defending any such loss, claim, damage, liability or
action as such expenses are incurred, it being understood and agreed that the
only such information furnished by any Underwriter consists of the following
information in the Prospectus furnished on behalf of each Underwriter: the
fourth, seventh, fifteenth, sixteenth and seventeenth paragraphs, and the last
two sentences in the eighth paragraph under the caption “Underwriting”.

     (d) Promptly after receipt by an indemnified party under this Section or
Section 9 of notice of the commencement of any action, such indemnified party
will, if a claim in respect thereof is to be made against an indemnifying party
under subsection (a), (b) or (c) above or Section 9, notify the indemnifying
party of the commencement thereof in writing; but the failure to notify the
indemnifying party shall not relieve it from any liability that it may have
under subsection (a), (b) or (c) above or Section 9 except to the extent that
it has been materially prejudiced (through the forfeiture of substantive rights
or defenses) by such failure; and provided further that the failure to notify
the indemnifying party shall not relieve it from any liability that it may have
to an indemnified party otherwise than under subsection (a), (b) or (c) above
or Section 9. In case any such action is brought against any indemnified party
and it notifies an indemnifying party of the commencement thereof, the
indemnifying party will be entitled to participate therein and, to the extent
that it may wish, jointly with any other indemnifying party similarly notified,
to assume the defense thereof, with counsel reasonably satisfactory to such
indemnified party (who shall not, except with the consent of the indemnified
party, be counsel to the indemnifying party), and after notice from the
indemnifying party to such indemnified party of its election so to assume the
defense thereof, the indemnifying party will not be liable to such indemnified
party under this Section or Section 9, as the case may be, for any legal or
other expenses subsequently incurred by such indemnified party in connection
with the defense thereof other than reasonable costs of investigation.
Notwithstanding anything contained herein to the contrary, if indemnity may be
sought pursuant to the last paragraph in Section 7 (a) hereof in respect of
such action or proceeding, then in addition to such separate firm for the
indemnified parties, the indemnifying party shall be liable for the reasonable
fees and expenses of not more than one separate firm (in addition to any local
counsel) for the Designated Underwriter for the defense of any losses, claims,
damages and liabilities arising out of the Directed Share Program, and all
persons, if any, who control the Designated Underwriter within the meaning of
either Section 15 of the Act of Section 20 of the Exchange Act. No indemnifying
party shall, without the prior written consent of the indemnified party, effect
any settlement of any pending or threatened action in respect of which any
indemnified party is or could have been a party and indemnity could have been
sought hereunder by such indemnified party unless such (i) settlement includes
an unconditional release of such indemnified party from all liability on any
claims that are the subject matter of such action and (ii) does not include a
statement as to, or an admission of, fault, culpability or a failure to act by
or on behalf of an indemnified party.

     (e) If the indemnification provided for in this Section is unavailable or
insufficient to hold harmless an indemnified party under subsection (a), (b) or
(c) above, then each indemnifying party shall contribute to the amount paid or
payable by such indemnified party as a

20

 

result of the losses, claims, damages or
liabilities referred to in subsection (a), (b) or (c) above (i) in such
proportion as is appropriate to reflect the relative benefits received by the
Company or such Selling Stockholder on the one hand and the Underwriters on the
other from the offering of the Securities or (ii) if the allocation provided by
clause (i) above is not permitted by applicable law, in such proportion as is
appropriate to reflect not only the relative benefits referred to in clause (i)
above but also the relative fault of the Company or such Selling Stockholder on
the one hand and the Underwriters on the other in connection with the
statements or omissions which resulted in such losses, claims, damages or
liabilities as well as any other relevant equitable considerations. The
relative benefits received by the Company or such Selling Stockholder on the
one hand and the Underwriters on the other shall be deemed to be in the same
proportion as the total net proceeds from the offering (before deducting
expenses) received by the Company or such Selling Stockholder bear to the total
underwriting discounts and commissions received by
the Underwriters. The relative fault shall be determined by reference to,
among other things, whether the untrue or alleged untrue statement of a
material fact or the omission or alleged omission to state a material fact
relates to information supplied by the Company, the Selling Stockholders or the
Underwriters and the parties’ relative intent, knowledge, access to information
and opportunity to correct or prevent such untrue statement or omission. The
amount paid by an indemnified party as a result of the losses, claims, damages
or liabilities referred to in the first sentence of this subsection (e) shall
be deemed to include any legal or other expenses reasonably incurred by such
indemnified party in connection with investigating or defending any action or
claim which is the subject of this subsection (e). Notwithstanding the
provisions of this subsection (e), no Underwriter shall be required to
contribute any amount in excess of the amount by which the total price at which
the Securities underwritten by it and distributed to the public were offered to
the public exceeds the amount of any damages which such Underwriter has
otherwise been required to pay by reason of such untrue or alleged untrue
statement or omission or alleged omission and no Selling Stockholder shall be
required to contribute an amount in excess of the net proceeds from the
offering actually received by such Selling Stockholder under this Agreement or
to contribute any amount in respect of losses, claims, damages or liabilities
that it would not be obligated to indemnify under Section 7(b). No person
guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of
the Act) shall be entitled to contribution from any person who was not guilty
of such fraudulent misrepresentation. The Underwriters’ obligations in this
subsection (e) to contribute are several in proportion to their respective
underwriting obligations and not joint.

     (f) The obligations of the Company and the Selling Stockholders under this
Section or Section 9 shall be in addition to any liability which the Company
and the Selling Stockholders may otherwise have and shall extend, upon the same
terms and conditions, to each person, if any, who controls any Underwriter or
the QIU (as hereinafter defined) within the meaning of the Act; and the
obligations of the Underwriters under this Section shall be in addition to any
liability which the respective Underwriters may otherwise have and shall
extend, upon the same terms and conditions, to each director of the Company, to
each officer of the Company who has signed a Registration Statement and to each
person, if any, who controls the Company within the meaning of the Act.

     (g) The aggregate liability of each Selling Stockholder under the
indemnity and contribution agreements contained in this Section 7 shall be
limited to an amount equal to the net

21

 

proceeds from the offering of the
Securities provided hereunder actually received by such Selling Stockholder
hereunder.

     8. Default of Underwriters. If any Underwriter or Underwriters default in
their obligations to purchase Offered Securities hereunder on either the First
or any Optional Closing Date and the aggregate number of shares of Offered
Securities that such defaulting Underwriter or Underwriters agreed but failed
to purchase does not exceed 10% of the total number of shares of Offered
Securities that the Underwriters are obligated to purchase on such Closing
Date, CSFB may make arrangements satisfactory to the Company and the Selling
Stockholders for the purchase of such Offered Securities by other persons,
including any of the Underwriters, but if no such arrangements are made by such
Closing Date, the non-defaulting Underwriters shall be obligated severally, in
proportion to their respective commitments hereunder, to purchase the Offered
Securities that such defaulting Underwriters agreed but failed to purchase on
such Closing Date. If any Underwriter or Underwriters so default and the
aggregate number of shares of Offered Securities with respect to
which such default or defaults occur exceeds 10% of the total number of
shares of Offered Securities that the Underwriters are obligated to purchase on
such Closing Date and arrangements satisfactory to CSFB, the Company and the
Selling Stockholders for the purchase of such Offered Securities by other
persons are not made within 36 hours after such default, this Agreement will
terminate without liability on the part of any non-defaulting Underwriter, the
Company or the Selling Stockholders, except as provided in Section 10 (provided
that if such default occurs with respect to Optional Securities after the First
Closing Date, this Agreement will not terminate as to the Firm Securities or
any Optional Securities purchased prior to such termination). As used in this
Agreement, the term “Underwriter” includes any person substituted for an
Underwriter under this Section. Nothing herein will relieve a defaulting
Underwriter from liability for its default.

     9. Qualified Independent Underwriter. The Company hereby confirms that at
its request CSFB has without compensation acted as “qualified independent
underwriter” (in such capacity, the “QIU”) within the meaning of Rule 2710 of
the Conduct Rules of the National Association of Securities Dealers, Inc. in
connection with the offering of the Offered Securities. The Company and the
Selling Stockholders will severally and not jointly indemnify and hold harmless
the QIU against any losses, claims, damages or liabilities, joint or several,
to which the QIU may become subject, under the Act or otherwise, insofar as
such losses, claims, damages or liabilities (or actions in respect thereof)
arise out of or are based upon the QIU’s acting (or alleged failing to act) as
such “qualified independent underwriter” and will reimburse the QIU for any
legal or other expenses reasonably incurred by the QIU in connection with
investigating or defending any such loss, claim, damage, liability or action as
such expenses are incurred.

     10. Survival of Certain Representations and Obligations. The respective
indemnities, agreements, representations, warranties and other statements of
the several Selling Stockholders, of the Company or its officers and of the
several Underwriters set forth in or made pursuant to this Agreement will
remain in full force and effect, regardless of any investigation, or statement
as to the results thereof, made by or on behalf of any Underwriter, any
Selling Stockholder, the Company or any of their respective representatives,
officers or directors or any controlling person, and will survive delivery of
and payment for the Offered Securities. If this Agreement is terminated
pursuant to Section 8 or if for any reason the purchase of the Offered
Securities by the Underwriters is not consummated, the Company and the Selling
Stockholders shall remain responsible for the expenses to be paid or reimbursed
by them pursuant to Section 5 and the respective obligations of

22

 

the Company,
the Selling Stockholders, and the Underwriters pursuant to Section 7 shall
remain in effect, and if any Offered Securities have been purchased hereunder
the representations and warranties in Section 2 and all obligations under
Section 5 shall also remain in effect. If the purchase of the Offered
Securities by the Underwriters is not consummated for any reason other than
solely because of the termination of this Agreement pursuant to Section 8 or
the occurrence of any event specified in clause (iii), (iv), (vi), (vii) or
(viii) of Section 6(c), the Company will reimburse the Underwriters for all
out-of-pocket expenses (including fees and disbursements of counsel) reasonably
incurred by them in connection with the offering of the Offered Securities.

     11. Notices. All communications hereunder will be in writing and, if sent
to the Underwriters, will be mailed, delivered or faxed and confirmed to the
Representative at Eleven Madison Avenue, New York, NY 10010-3629, Attention:
Transactions Advisory Group, or, if sent to the Company, will be mailed,
delivered or faxed and confirmed to it at Commercial Vehicle Group, Inc., 6530
West Campus Way, New Albany, Ohio 43054, Attention: Mervin Dunn, President and
Chief Executive Officer, or, if sent to the Selling Stockholders or any of
them, will be
mailed, delivered or faxed and confirmed to each of them at its respective
address set forth on Schedule A hereto; provided, however, that any notice to
an Underwriter pursuant to Section 7 will be mailed, delivered or telegraphed
and confirmed to such Underwriter.

     12. Successors. This Agreement will inure to the benefit of and be binding
upon the parties hereto and their respective personal representatives and
successors and the officers and directors and controlling persons referred to
in Section 7, and no other person will have any right or obligation hereunder.

     13. Representation. The Representative will act for the several
Underwriters in connection with the transactions contemplated by this
Agreement, and any action under this Agreement taken by the Representative will
be binding upon all the Underwriters. Hidden Creek Industries will act for the
Custodial Selling Stockholders in connection with such transactions, and any
action under or in respect of this Agreement taken by Hidden Creek Industries
will be binding upon all the Custodial Selling Stockholders. Onex American
Holdings II LLC will act for the Onex Selling Stockholders in connection with
such transactions, and any action under or in respect of this Agreement taken
by Onex American Holdings II LLC will be binding upon all the Onex Selling
Stockholders.

     14. Counterparts. This Agreement may be executed in any number of
counterparts, each of which shall be deemed to be an original, but all such
counterparts shall together constitute one and the same Agreement.

     15. Applicable Law. This Agreement shall be governed by, and construed in
accordance with, the laws of the State of New York.

     The Company hereby submits to the non-exclusive jurisdiction of the
Federal and state courts in the Borough of Manhattan in The City of New York in
any suit or proceeding arising out of or relating to this Agreement or the
transactions contemplated hereby.

23

 

     If the foregoing is in accordance with the Representative’s understanding
of our agreement, kindly sign and return to the Company one of the counterparts
hereof, whereupon it will become a binding agreement among the Selling
Stockholders, the Company and the several Underwriters in accordance with its
terms.

	 	 	 	 	 	 	 	 	 
	 	 	Very truly yours,
	 
	 	 	 	 	 	 	 	 
	 	 	 	 	COMMERCIAL VEHICLE GROUP, INC.,
	 
	 	 	 	 	 	 	 	 
	

	 	 	 	 	 	By
	 	  /s/ Chad M. Utrup
	

	 	 	 	 	 	 	 	
 
	

	 	 	 	 	 	 	 	Name: Chad M. Utrup
	

	 	 	 	 	 	 	 	Title: Vice President & CFO
	 
	 	 	 	 	 	 	 	 
	 	 	 	 	ONEX AMERICAN HOLDINGS II LLC,
	 
	 	 	 	 	 	 	 	 
	

	 	 	 	 	 	By
	 	  /s/ Eric J. Rosen
	

	 	 	 	 	 	 	 	
 
	

	 	 	 	 	 	 	 	Name:
	

	 	 	 	 	 	 	 	Title:
	 
	 	 	 	 	 	 	 	 
	 	 	 	 	BOSTROM EXECUTIVE INVESTCO LLC,
	 
	 	 	 	 	 	 	 	 
	

	 	 	 	 	 	By
	 	  /s/ Eric J. Rosen
	

	 	 	 	 	 	 	 	
 
	

	 	 	 	 	 	 	 	Name:
	

	 	 	 	 	 	 	 	Title:
	 
	 	 	 	 	 	 	 	 
	 	 	 	 	CVS EXECUTIVE INVESTCO LLC,
	 
	 	 	 	 	 	 	 	 
	

	 	 	 	 	 	By
	 	  /s/ Eric J. Rosen
	

	 	 	 	 	 	 	 	
 
	

	 	 	 	 	 	 	 	Name:
	

	 	 	 	 	 	 	 	Title:
	 
	 	 	 	 	 	 	 	 
	 	 	 	 	ONEX DHC LLC,
	 
	 	 	 	 	 	 	 	 
	

	 	 	 	 	 	By
	 	  /s/ Eric J. Rosen
	

	 	 	 	 	 	 	 	
 
	

	 	 	 	 	 	 	 	Name:
	

	 	 	 	 	 	 	 	Title:

24

 

	 	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	 	 	TRIM SYSTEMS EXECUTIVE INVESTCO LLC,
	 
	 	 	 	 	 	 	 	 
	

	 	 	 	 	 	By
	 	  /s/ Eric J. Rosen
	

	 	 	 	 	 	 	 	
 
	

	 	 	 	 	 	 	 	Name:
	

	 	 	 	 	 	 	 	Title:
	 
	 	 	 	 	 	 	 	 
	 	 	 	 	TRIM SYSTEMS EXECUTIVE INVESTCO II LLC,
	 
	 	 	 	 	 	 	 	 
	

	 	 	 	 	 	By
	 	  /s/ Eric J. Rosen
	

	 	 	 	 	 	 	 	
 
	

	 	 	 	 	 	 	 	Name:
	

	 	 	 	 	 	 	 	Title:
	 
	 	 	 	 	 	 	 	 
	 	 	 	 	BOSTROM PARTNERS LP,
	 
	 	 	 	 	 	 	 	 
	

	 	 	 	 	 	By
	 	  /s/ Eric J. Rosen
	

	 	 	 	 	 	 	 	
 
	

	 	 	 	 	 	 	 	Name:
	

	 	 	 	 	 	 	 	Title:
	 
	 	 	 	 	 	 	 	 
	 	 	 	 	1170821 ONTARIO INC.,
	 
	 	 	 	 	 	 	 	 
	

	 	 	 	 	 	By
	 	  /s/ Eric J. Rosen
	

	 	 	 	 	 	 	 	
 
	

	 	 	 	 	 	 	 	Name:
	

	 	 	 	 	 	 	 	Title:
	 
	 	 	 	 	 	 	 	 
	 	 	 	 	1170809 ONTARIO INC.,
	 
	 	 	 	 	 	 	 	 
	

	 	 	 	 	 	By
	 	  /s/ Eric J. Rosen
	

	 	 	 	 	 	 	 	
 
	

	 	 	 	 	 	 	 	Name:
	

	 	 	 	 	 	 	 	Title:
	 
	 	 	 	 	 	 	 	 
	 	 	 	 	1170812 ONTARIO INC.,
	 
	 	 	 	 	 	 	 	 
	

	 	 	 	 	 	By
	 	  /s/ Eric J. Rosen
	

	 	 	 	 	 	 	 	
 
	

	 	 	 	 	 	 	 	Name:
	

	 	 	 	 	 	 	 	Title:

25

 

	 	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	 	 	KYZALEA COMPANY,
	 
	 	 	 	 	 	 	 	 
	

	 	 	 	 	 	By
	 	  /s/ Eric J. Rosen
	

	 	 	 	 	 	 	 	
 
	

	 	 	 	 	 	 	 	Name:
	

	 	 	 	 	 	 	 	Title:
	 
	 	 	 	 	 	 	 	 
	 	 	 	 	1170819 ONTARIO INC.,
	 
	 	 	 	 	 	 	 	 
	

	 	 	 	 	 	By
	 	  /s/ Eric J. Rosen
	

	 	 	 	 	 	 	 	
 
	

	 	 	 	 	 	 	 	Name:
	

	 	 	 	 	 	 	 	Title:
	 
	 	 	 	 	 	 	 	 
	 	 	 	 	1170698 ONTARIO INC.,
	 
	 	 	 	 	 	 	 	 
	

	 	 	 	 	 	By
	 	  /s/ Eric J. Rosen
	

	 	 	 	 	 	 	 	
 
	

	 	 	 	 	 	 	 	Name:
	

	 	 	 	 	 	 	 	Title:
	 
	 	 	 	 	 	 	 	 
	 	 	 	 	1301449 ONTARIO INC.,
	 
	 	 	 	 	 	 	 	 
	

	 	 	 	 	 	By
	 	  /s/ Eric J. Rosen
	

	 	 	 	 	 	 	 	
 
	

	 	 	 	 	 	 	 	Name:
	

	 	 	 	 	 	 	 	Title:
	 
	 	 	 	 	 	 	 	 
	 	 	 	 	1352536 ONTARIO INC.
	 
	 	 	 	 	 	 	 	 
	

	 	 	 	 	 	By
	 	  /s/ Eric J. Rosen
	

	 	 	 	 	 	 	 	
 
	

	 	 	 	 	 	 	 	Name:
	

	 	 	 	 	 	 	 	Title:
	 
	 	 	 	 	 	 	 	 
	 	 	 	 	1376653 ONTARIO INC.,
	 
	 	 	 	 	 	 	 	 
	

	 	 	 	 	 	By
	 	  /s/ Eric J. Rosen
	

	 	 	 	 	 	 	 	
 
	

	 	 	 	 	 	 	 	Name:
	

	 	 	 	 	 	 	 	Title:

26

 

	 	 	 	 	 	 	 	 	 
	 	 	 	 	1352537 ONTARIO INC.,
	 
	 	 	 	 	 	 	 	 
	

	 	 	 	 	 	By
	 	  /s/ Eric J. Rosen
	

	 	 	 	 	 	 	 	
 
	

	 	 	 	 	 	 	 	Name:
	

	 	 	 	 	 	 	 	Title:
	 
	 	 	 	 	 	 	 	 
	 	 	 	 	TIM DUNCANSON,
	 
	 	 	 	 	 	 	 	 
	

	 	 	 	 	 	By
	 	  /s/ Eric J. Rosen
	

	 	 	 	 	 	 	 	
 
	

	 	 	 	 	 	 	 	Name:
	

	 	 	 	 	 	 	 	Title:
	 
	 	 	 	 	 	 	 	 
	 	 	 	 	3-G INVESTMENTS LIMITED,
	 
	 	 	 	 	 	 	 	 
	

	 	 	 	 	 	By
	 	  /s/ Eric J. Rosen
	

	 	 	 	 	 	 	 	
 
	

	 	 	 	 	 	 	 	Name:
	

	 	 	 	 	 	 	 	Title:
	 
	 	 	 	 	 	 	 	 
	 	 	 	 	SERGE GOUIN,
	 
	 	 	 	 	 	 	 	 
	

	 	 	 	 	 	By
	 	  /s/ Eric J. Rosen
	

	 	 	 	 	 	 	 	
 
	

	 	 	 	 	 	 	 	Name:
	

	 	 	 	 	 	 	 	Title:
	 
	 	 	 	 	 	 	 	 
	 	 	 	 	BRIAN KING,
	 
	 	 	 	 	 	 	 	 
	

	 	 	 	 	 	By
	 	  /s/ Eric J. Rosen
	

	 	 	 	 	 	 	 	
 
	

	 	 	 	 	 	 	 	Name:
	

	 	 	 	 	 	 	 	Title:
	 
	 	 	 	 	 	 	 	 
	 	 	 	 	J.W.E. MINGO,
	 
	 	 	 	 	 	 	 	 
	

	 	 	 	 	 	By
	 	  /s/ Eric J. Rosen
	

	 	 	 	 	 	 	 	
 
	

	 	 	 	 	 	 	 	Name:
	

	 	 	 	 	 	 	 	Title:

27

 

	 	 	 	 	 	 	 	 	 
	 	 	 	 	ROBERT PRICHARD,
	 
	 	 	 	 	 	 	 	 
	

	 	 	 	 	 	By
	 	  /s/ Eric J. Rosen
	

	 	 	 	 	 	 	 	
 
	

	 	 	 	 	 	 	 	Name:
	

	 	 	 	 	 	 	 	Title:
	 
	 	 	 	 	 	 	 	 
	 	 	 	 	1299039 ONTARIO INC.,
	 
	 	 	 	 	 	 	 	 
	

	 	 	 	 	 	By
	 	  /s/ Eric J. Rosen
	

	 	 	 	 	 	 	 	
 
	

	 	 	 	 	 	 	 	Name:
	

	 	 	 	 	 	 	 	Title:
	 
	 	 	 	 	 	 	 	 
	 	 	 	 	2668921 MANITOBA LTD.,
	 
	 	 	 	 	 	 	 	 
	

	 	 	 	 	 	By
	 	  /s/ Eric J. Rosen
	

	 	 	 	 	 	 	 	
 
	

	 	 	 	 	 	 	 	Name:
	

	 	 	 	 	 	 	 	Title:
	 
	 	 	 	 	 	 	 	 
	 	 	 	 	ONEX ADVISOR III LLC,
	 
	 	 	 	 	 	 	 	 
	

	 	 	 	 	 	By
	 	  /s/ Eric J. Rosen
	

	 	 	 	 	 	 	 	
 
	

	 	 	 	 	 	 	 	Name:
	

	 	 	 	 	 	 	 	Title:
	 
	 	 	 	 	 	 	 	 
	 	 	 	 	CVS PARTNERS, LP,
	 
	 	 	 	 	 	 	 	 
	

	 	 	 	 	 	By
	 	  /s/ Eric J. Rosen
	

	 	 	 	 	 	 	 	
 
	

	 	 	 	 	 	 	 	Name:
	

	 	 	 	 	 	 	 	Title:
	 
	 	 	 	 	 	 	 	 
	 	 	 	 	3062601 NOVA SCOTIA COMPANY,
	 
	 	 	 	 	 	 	 	 
	

	 	 	 	 	 	By
	 	  /s/ Eric J. Rosen
	

	 	 	 	 	 	 	 	
 
	

	 	 	 	 	 	 	 	Name:
	

	 	 	 	 	 	 	 	Title:

28

 

	 	 	 	 	 	 	 	 	 
	 	 	 	 	HIDDEN CREEK INDUSTRIES,
	 
	 	 	 	 	 	 	 	 
	

	 	 	 	 	 	By
	 	  /s/ Daniel F. Moorse
	

	 	 	 	 	 	 	 	
 
	

	 	 	 	 	 	 	 	Name:
	

	 	 	 	 	 	 	 	Title:
	 
	 	 	 	 	 	 	 	 
	 	 	 	 	AMON CANADIAN INVESTMENTS LTD.,
	 
	 	 	 	 	 	 	 	 
	

	 	 	 	 	 	By
	 	  /s/ Eric J. Rosen
	

	 	 	 	 	 	 	 	
 
	

	 	 	 	 	 	 	 	Name:
	

	 	 	 	 	 	 	 	Title:
	 
	 	 	 	 	 	 	 	 
	 	 	 	 	MHON CANADIAN INVESTMENTS LTD.,
	 
	 	 	 	 	 	 	 	 
	

	 	 	 	 	 	By
	 	  /s/ Eric J. Rosen
	

	 	 	 	 	 	 	 	
 
	

	 	 	 	 	 	 	 	Name:
	

	 	 	 	 	 	 	 	Title:
	 
	 	 	 	 	 	 	 	 
	 	 	 	 	BAIRD CAPITAL PARTNERS III L.P.,
	 
	 	 	 	 	 	 	 	 
	

	 	 	 	 	 	By
	 	  /s/ Daniel F. Moorse
	

	 	 	 	 	 	 	 	
 
	

	 	 	 	 	 	 	 	Name:
	

	 	 	 	 	 	 	 	Title:
	 
	 	 	 	 	 	 	 	 
	 	 	 	 	BAIRD CAPITAL PARTNERS II L.P.,
	 
	 	 	 	 	 	 	 	 
	

	 	 	 	 	 	By
	 	  /s/ Daniel F. Moorse
	

	 	 	 	 	 	 	 	
 
	

	 	 	 	 	 	 	 	Name:
	

	 	 	 	 	 	 	 	Title:
	 
	 	 	 	 	 	 	 	 
	 	 	 	 	BCP III AFFILIATES FUND L.P.,
	 
	 	 	 	 	 	 	 	 
	

	 	 	 	 	 	By
	 	  /s/ Daniel F. Moorse
	

	 	 	 	 	 	 	 	
 
	

	 	 	 	 	 	 	 	Name:
	

	 	 	 	 	 	 	 	Title:

29

 

	 	 	 	 	 	 	 	 	 
	 	 	 	 	BCP III SPECIAL AFFILIATES L.P.,
	 
	 	 	 	 	 	 	 	 
	

	 	 	 	 	 	By
	 	  /s/ Daniel F. Moorse
	

	 	 	 	 	 	 	 	
 
	

	 	 	 	 	 	 	 	Name:
	

	 	 	 	 	 	 	 	Title:
	 
	 	 	 	 	 	 	 	 
	 	 	 	 	BCP II AFFILIATES FUND L.P.,
	 
	 	 	 	 	 	 	 	 
	

	 	 	 	 	 	By
	 	  /s/ Daniel F. Moorse
	

	 	 	 	 	 	 	 	
 
	

	 	 	 	 	 	 	 	Name:
	

	 	 	 	 	 	 	 	Title:
	 
	 	 	 	 	 	 	 	 
	 	 	 	 	NORWEST EQUITY PARTNERS VII L.P.,
	 
	 	 	 	 	 	 	 	 
	

	 	 	 	 	 	By
	 	  /s/ Daniel F. Moorse
	

	 	 	 	 	 	 	 	
 
	

	 	 	 	 	 	 	 	Name:
	

	 	 	 	 	 	 	 	Title:
	 
	 	 	 	 	 	 	 	 
	 	 	 	 	KENNETH W. HAGER,
	 
	 	 	 	 	 	 	 	 
	

	 	 	 	 	 	By
	 	  /s/ Daniel F. Moorse
	

	 	 	 	 	 	 	 	
 
	

	 	 	 	 	 	 	 	Name:
	

	 	 	 	 	 	 	 	Title:
	 
	 	 	 	 	 	 	 	 
	 	 	 	 	DAVID J. HULS,
	 
	 	 	 	 	 	 	 	 
	

	 	 	 	 	 	By
	 	  /s/ Daniel F. Moorse
	

	 	 	 	 	 	 	 	
 
	

	 	 	 	 	 	 	 	Name:
	

	 	 	 	 	 	 	 	Title:
	 
	 	 	 	 	 	 	 	 
	 	 	 	 	S.A. JOHNSON,
	 
	 	 	 	 	 	 	 	 
	

	 	 	 	 	 	By
	 	  /s/ Daniel F. Moorse
	

	 	 	 	 	 	 	 	
 
	

	 	 	 	 	 	 	 	Name:
	

	 	 	 	 	 	 	 	Title:

30

 

	 	 	 	 	 	 	 	 	 
	 	 	 	 	DANIEL F. MOORSE,
	 
	 	 	 	 	 	 	 	 
	

	 	 	 	 	 	By
	 	  /s/ Daniel F. Moorse
	

	 	 	 	 	 	 	 	
 
	

	 	 	 	 	 	 	 	Name:
	

	 	 	 	 	 	 	 	Title:
	 
	 	 	 	 	 	 	 	 
	 	 	 	 	CARL E. NELSON,
	 
	 	 	 	 	 	 	 	 
	

	 	 	 	 	 	By
	 	  /s/ Daniel F. Moorse
	

	 	 	 	 	 	 	 	
 
	

	 	 	 	 	 	 	 	Name:
	

	 	 	 	 	 	 	 	Title:
	 
	 	 	 	 	 	 	 	 
	 	 	 	 	JUDITH A. VIJUMS,
	 
	 	 	 	 	 	 	 	 
	

	 	 	 	 	 	By
	 	  /s/ Daniel F. Moorse
	

	 	 	 	 	 	 	 	
 
	

	 	 	 	 	 	 	 	Name:
	

	 	 	 	 	 	 	 	Title:
	 
	 	 	 	 	 	 	 	 
	 	 	 	 	MARNI L. NAGY,
	 
	 	 	 	 	 	 	 	 
	

	 	 	 	 	 	By
	 	  /s/ Daniel F. Moorse
	

	 	 	 	 	 	 	 	
 
	

	 	 	 	 	 	 	 	Name:
	

	 	 	 	 	 	 	 	Title:
	 
	 	 	 	 	 	 	 	 
	 	 	 	 	RONALD A. JOHNSON,
	 
	 	 	 	 	 	 	 	 
	

	 	 	 	 	 	By
	 	  /s/ Daniel F. Moorse
	

	 	 	 	 	 	 	 	
 
	

	 	 	 	 	 	 	 	Name:
	

	 	 	 	 	 	 	 	Title:
	 
	 	 	 	 	 	 	 	 
	 	 	 	 	RANDOLPH STREET PARTNERS II,
	 
	 	 	 	 	 	 	 	 
	

	 	 	 	 	 	By
	 	  /s/ Daniel F. Moorse
	

	 	 	 	 	 	 	 	
 
	

	 	 	 	 	 	 	 	Name:
	

	 	 	 	 	 	 	 	Title:

31

 

	 	 	 	 	 	 	 	 	 
	 	 	 	 	ROBERT R. HIBBS,
	 
	 	 	 	 	 	 	 	 
	

	 	 	 	 	 	By
	 	  /s/ Daniel F. Moorse
	

	 	 	 	 	 	 	 	
 
	

	 	 	 	 	 	 	 	Name:
	

	 	 	 	 	 	 	 	Title:
	 
	 	 	 	 	 	 	 	 
	 	 	 	 	MARY-LOUISE R. JOHNSON TRUST,
	 
	 	 	 	 	 	 	 	 
	

	 	 	 	 	 	By
	 	  /s/ Daniel F. Moorse
	

	 	 	 	 	 	 	 	
 
	

	 	 	 	 	 	 	 	Name:
	

	 	 	 	 	 	 	 	Title:
	 
	 	 	 	 	 	 	 	 
	 	 	 	 	MICHAEL SZCZEPANSKI,
	 
	 	 	 	 	 	 	 	 
	

	 	 	 	 	 	By
	 	  /s/ Daniel F. Moorse
	

	 	 	 	 	 	 	 	
 
	

	 	 	 	 	 	 	 	Name:
	

	 	 	 	 	 	 	 	Title:
	 
	 	 	 	 	 	 	 	 
	 	 	 	 	ASC INCORPORATED,
	 
	 	 	 	 	 	 	 	 
	

	 	 	 	 	 	By
	 	  /s/ Daniel F. Moorse
	

	 	 	 	 	 	 	 	
 
	

	 	 	 	 	 	 	 	Name:
	

	 	 	 	 	 	 	 	Title:

32

 

The foregoing Underwriting Agreement
is hereby confirmed and accepted
as of the date first above
written.

	 	 	 	 	 	 	 
	 	 	CREDIT SUISSE FIRST BOSTON LLC	 	 
	 
	 	 	 	 	 	 
	

	 	By
	 	/s/ Edward P. Witz

	 	 
	

	 	 	 	Name: Edward P. Witz	 	 
	

	 	 	 	Title: Managing Director	 	 

Acting on behalf of itself and as
the Representative of the
several Underwriters.

33

 

SCHEDULE A

	 	 	 	 	 	 	 
	 	 	 	 	Number of Firm
	 	 	 	 	Securities
	Selling Stockholder
	 	Address
	 	to be Sold

	Onex American Holdings II LLC

	 	c/o Onex Investment Corp.
	 	 	2,159,033	 
	

	 	712 Fifth Avenue	 	 	 	 
	

	 	New York, NY 10019	 	 	 	 
	 
	 	 	 	 	 	 
	Bostrom Executive Investco LLC

	 	c/o Onex Investment Corp.
	 	 	94,389	 
	

	 	712 Fifth Avenue	 	 	 	 
	

	 	New York, NY 10019	 	 	 	 
	 
	 	 	 	 	 	 
	CVS Executive Investco LLC

	 	c/o Onex Investment Corp.
	 	 	66,197	 
	

	 	712 Fifth Avenue	 	 	 	 
	

	 	New York, NY 10019	 	 	 	 
	 
	 	 	 	 	 	 
	Onex DHC LLC

	 	c/o Onex Investment Corp.
	 	 	1,008,939	 
	

	 	712 Fifth Avenue	 	 	 	 
	

	 	New York, NY 10019	 	 	 	 
	 
	 	 	 	 	 	 
	Trim Systems Executive Investco LLC

	 	c/o Onex Investment Corp.
	 	 	39,194	 
	

	 	712 Fifth Avenue	 	 	 	 
	

	 	New York, NY 10019	 	 	 	 
	 
	 	 	 	 	 	 
	Trim Systems Executive Investco II LLC

	 	c/o Onex Investment Corp.
	 	 	33,422	 
	

	 	712 Fifth Avenue	 	 	 	 
	

	 	New York, NY 10019	 	 	 	 
	 
	 	 	 	 	 	 
	Bostrom Partners LP

	 	c/o Onex Investment Corp.
	 	 	21,983	 
	

	 	712 Fifth Avenue	 	 	 	 
	

	 	New York, NY 10019	 	 	 	 
	 
	 	 	 	 	 	 
	1170821 Ontario Inc.

	 	c/o Onex Investment Corp.
	 	 	15,675	 
	

	 	712 Fifth Avenue	 	 	 	 
	

	 	New York, NY 10019	 	 	 	 
	 
	 	 	 	 	 	 
	1170809 Ontario Inc.

	 	c/o Onex Investment Corp.
	 	 	13,166	 
	

	 	712 Fifth Avenue	 	 	 	 
	

	 	New York, NY 10019	 	 	 	 
	 
	 	 	 	 	 	 
	1170812 Ontario Inc.

	 	c/o Onex Investment Corp.
	 	 	22,495	 
	

	 	712 Fifth Avenue	 	 	 	 
	

	 	New York, NY 10019	 	 	 	 
	 
	 	 	 	 	 	 
	Kyzalea Company

	 	c/o Onex Investment Corp.
	 	 	7,202	 
	

	 	712 Fifth Avenue	 	 	 	 
	

	 	New York, NY 10019	 	 	 	 

34

 

	 	 	 	 	 	 	 
	 	 	 	 	Number of Firm
	 	 	 	 	Securities
	Selling Stockholder
	 	Address
	 	to be Sold

	1170819 Ontario Inc.

	 	c/o Onex Investment Corp.
	 	 	5,227	 
	

	 	712 Fifth Avenue	 	 	 	 
	

	 	New York, NY 10019	 	 	 	 
	 
	 	 	 	 	 	 
	1170698 Ontario Inc.

	 	c/o Onex Investment Corp.
	 	 	4,518	 
	

	 	712 Fifth Avenue	 	 	 	 
	

	 	New York, NY 10019	 	 	 	 
	 
	 	 	 	 	 	 
	1301449 Ontario Inc.

	 	c/o Onex Investment Corp.
	 	 	2,063	 
	

	 	712 Fifth Avenue	 	 	 	 
	

	 	New York, NY 10019	 	 	 	 
	 
	 	 	 	 	 	 
	1352536 Ontario Inc.

	 	c/o Onex Investment Corp.
	 	 	1,158	 
	

	 	712 Fifth Avenue	 	 	 	 
	

	 	New York, NY 10019	 	 	 	 
	 
	 	 	 	 	 	 
	1376653 Ontario Inc.

	 	c/o Onex Investment Corp.
	 	 	493	 
	

	 	712 Fifth Avenue	 	 	 	 
	

	 	New York, NY 10019	 	 	 	 
	 
	 	 	 	 	 	 
	1352537 Ontario Inc.

	 	c/o Onex Investment Corp.
	 	 	147	 
	

	 	712 Fifth Avenue	 	 	 	 
	

	 	New York, NY 10019	 	 	 	 
	 
	 	 	 	 	 	 
	Tim Duncanson

	 	c/o Onex Investment Corp.
	 	 	439	 
	

	 	712 Fifth Avenue	 	 	 	 
	

	 	New York, NY 10019	 	 	 	 
	 
	 	 	 	 	 	 
	3-G Investments Limited

	 	c/o Onex Investment Corp.
	 	 	13,180	 
	

	 	712 Fifth Avenue	 	 	 	 
	

	 	New York, NY 10019	 	 	 	 
	 
	 	 	 	 	 	 
	Serge Gouin

	 	c/o Onex Investment Corp.
	 	 	8,787	 
	

	 	712 Fifth Avenue	 	 	 	 
	

	 	New York, NY 10019	 	 	 	 
	 
	 	 	 	 	 	 
	Brian King

	 	c/o Onex Investment Corp.
	 	 	1,318	 
	

	 	712 Fifth Avenue	 	 	 	 
	

	 	New York, NY 10019	 	 	 	 
	 
	 	 	 	 	 	 
	J.W.E. Mingo

	 	c/o Onex Investment Corp.
	 	 	879	 
	

	 	712 Fifth Avenue	 	 	 	 
	

	 	New York, NY 10019	 	 	 	 
	 
	 	 	 	 	 	 
	Robert Prichard

	 	c/o Onex Investment Corp.
	 	 	4,393	 
	

	 	712 Fifth Avenue	 	 	 	 
	

	 	New York, NY 10019	 	 	 	 

35

 

	 	 	 	 	 	 	 
	 	 	 	 	Number of Firm
	 	 	 	 	Securities
	Selling Stockholder
	 	Address
	 	to be Sold

	1299039 Ontario Inc.

	 	c/o Onex Investment Corp.
	 	 	879	 
	

	 	712 Fifth Avenue	 	 	 	 
	

	 	New York, NY 10019	 	 	 	 
	 
	 	 	 	 	 	 
	2668921 Manitoba Ltd.

	 	c/o Onex Investment Corp.
	 	 	2636	 
	

	 	712 Fifth Avenue	 	 	 	 
	

	 	New York, NY 10019	 	 	 	 
	 
	 	 	 	 	 	 
	Onex Advisor III LLC

	 	c/o Onex Investment Corp.
	 	 	257,546	 
	

	 	712 Fifth Avenue	 	 	 	 
	

	 	New York, NY 10019	 	 	 	 
	 
	 	 	 	 	 	 
	CVS Partners, LP

	 	c/o Onex Investment Corp.
	 	 	15,417	 
	

	 	712 Fifth Avenue	 	 	 	 
	

	 	New York, NY 10019	 	 	 	 
	 
	 	 	 	 	 	 
	3062601 Nova Scotia Company

	 	c/o Onex Investment Corp.
	 	 	20,035	 
	

	 	712 Fifth Avenue	 	 	 	 
	

	 	New York, NY 10019	 	 	 	 
	 
	 	 	 	 	 	 
	Hidden Creek Industries

	 	4508 IDS Center
	 	 	44,195	 
	

	 	Minneapolis, MN 55402	 	 	 	 
	 
	 	 	 	 	 	 
	AMON Canadian Investments Ltd.

	 	c/o Onex Investment Corp.
	 	 	2,002	 
	

	 	712 Fifth Avenue	 	 	 	 
	

	 	New York, NY 10019	 	 	 	 
	 
	 	 	 	 	 	 
	MHON Canadian Investments Ltd.

	 	c/o Onex Investment Corp.
	 	 	1,891	 
	

	 	712 Fifth Avenue	 	 	 	 
	

	 	New York, NY 10019	 	 	 	 
	 
	 	 	 	 	 	 
	Baird Capital Partners III L.P.

	 	c/o Baird Capital Partners
	 	 	564,958	 
	

	 	227 West Monroe Street	 	 	 	 
	

	 	Suite 2200	 	 	 	 
	

	 	Chicago, IL 60606	 	 	 	 
	

	 	Attn: C. Andrew Brickman	 	 	 	 
	 
	 	 	 	 	 	 
	Baird Capital Partners II L.P.

	 	c/o Baird Capital Partners
	 	 	117,840	 
	

	 	227 West Monroe Street	 	 	 	 
	

	 	Suite 2200	 	 	 	 
	

	 	Chicago, IL 60606	 	 	 	 
	

	 	Attn: C. Andrew Brickman	 	 	 	 

36

 

	 	 	 	 	 	 	 
	 	 	 	 	Number of Firm
	 	 	 	 	Securities
	Selling Stockholder
	 	Address
	 	to be Sold

	BCP III Affiliates Fund L.P.

	 	c/o Baird Capital Partners
	 	 	112,999	 
	

	 	227 West Monroe Street	 	 	 	 
	

	 	Suite 2200	 	 	 	 
	

	 	Chicago, IL 60606	 	 	 	 
	

	 	Attn: C. Andrew Brickman	 	 	 	 
	 
	 	 	 	 	 	 
	BCP III Special Affiliates L.P.

	 	c/o Baird Capital Partners
	 	 	80,611	 
	

	 	227 West Monroe Street	 	 	 	 
	

	 	Suite 2200	 	 	 	 
	

	 	Chicago, IL 60606	 	 	 	 
	

	 	Attn: C. Andrew Brickman	 	 	 	 
	 
	 	 	 	 	 	 
	BCP II Affiliates Fund L.P.

	 	c/o Baird Capital Partners
	 	 	69,924	 
	

	 	227 West Monroe Street	 	 	 	 
	

	 	Suite 2200	 	 	 	 
	

	 	Chicago, IL 60606	 	 	 	 
	

	 	Attn: C. Andrew Brickman	 	 	 	 
	 
	 	 	 	 	 	 
	Norwest Equity Partners VII L.P.

	 	3600 IDS Center
	 	 	1,006,416	 
	

	 	80 South 8th Street	 	 	 	 
	

	 	Minneapolis, MN 55402	 	 	 	 
	 
	 	 	 	 	 	 
	Kenneth W. Hager

	 	c/o Hidden Creek
	 	 	10,820	 
	

	 	4508 IDS Center	 	 	 	 
	

	 	Minneapolis, MN 55402	 	 	 	 
	 
	 	 	 	 	 	 
	David J. Huls

	 	c/o Hidden Creek
	 	 	20,744	 
	

	 	4508 IDS Center	 	 	 	 
	

	 	Minneapolis, MN 55402	 	 	 	 
	 
	 	 	 	 	 	 
	S.A. Johnson

	 	c/o OG Partners
	 	 	103,452	 
	

	 	294 Grove Lane East	 	 	 	 
	

	 	Ste. 260	 	 	 	 
	

	 	Wayzata, MN 55391	 	 	 	 
	 
	 	 	 	 	 	 
	Daniel F. Moorse

	 	c/o Hidden Creek
	 	 	18,618	 
	

	 	4508 IDS Center	 	 	 	 
	

	 	Minneapolis, MN 55402	 	 	 	 
	 
	 	 	 	 	 	 
	Carl E. Nelson

	 	c/o Hidden Creek
	 	 	22,005	 
	

	 	4508 IDS Center	 	 	 	 
	

	 	Minneapolis, MN 55402	 	 	 	 
	 
	 	 	 	 	 	 
	Judith A. Vijums

	 	c/o Hidden Creek
	 	 	18,933	 
	

	 	4508 IDS Center	 	 	 	 
	

	 	Minneapolis, MN 55402	 	 	 	 

37

 

	 	 	 	 	 	 	 
	 	 	 	 	Number of Firm
	 	 	 	 	Securities
	Selling Stockholder
	 	Address
	 	to be Sold

	Marni L. Nagy

	 	20072 Trabuco Oaks Drive
	 	 	4,819	 
	

	 	PO Box 987	 	 	 	 
	

	 	Trabuco Canyon, CA 92678	 	 	 	 
	 
	 	 	 	 	 	 
	Ronald A. Johnson

	 	3702 Moorpark Avenue
	 	 	4,819	 
	

	 	San Jose, CA 95117	 	 	 	 
	 
	 	 	 	 	 	 
	Randolph Street Partners II

	 	c/o Kirkland & Ellis LLP
	 	 	33,804	 
	

	 	200 E. Randolph Drive	 	 	 	 
	

	 	Chicago, IL 60601	 	 	 	 
	 
	 	 	 	 	 	 
	Robert R. Hibbs

	 	3415 NE 2nd Avenue
	 	 	2,522	 
	

	 	Suite 203	 	 	 	 
	

	 	Miami, FL 33137	 	 	 	 
	 
	 	 	 	 	 	 
	Mary-Louise R. Johnson Trust

	 	c/o Hidden Creek
	 	 	1,261	 
	

	 	4508 IDS Center	 	 	 	 
	

	 	Minneapolis, MN 55402	 	 	 	 
	 
	 	 	 	 	 	 
	Michael Szczepanski

	 	5104 N. Graham
	 	 	861	 
	

	 	Charlotte, NC 28269	 	 	 	 
	 
	 	 	 	 	 	 
	ASC Incorporated

	 	One ASC Center
	 	 	60,696	 
	 

	 	Southgate, MI 48195	 	 	 	 
	

	 	 	 	 	
 	 
	Total

	 	 	 	 	6,125,000	 
	

	 	 	 	 	
 	 

38

 

SCHEDULE B

	 	 	 	 	 
	 	 	Number of
	 	 	Firm Securities
	Underwriter
	 	to be Purchased

	Credit Suisse First Boston LLC
	 	 	4,301,250	 
	Lehman Brothers Inc.
	 	 	2,127,500	 
	Robert W. Baird & Co. Incorporated
	 	 	2,127,500	 
	RBC Capital Markets Corporation
	 	 	693,750	 
	 
	 	 	
 	 
	Total
	 	 	9,250,000	 
	 
	 	 	
 	 

39

 

SCHEDULE C

SUBSIDIARIES OF COMMERCIAL VEHICLE GROUP, INC.

	 	 	 	 	 	 	 
	 	 	 	 	 	 	Significant
	 	 	Entity
	 	Jurisdiction
	 	Subsidiary

	1.

	 	Trim Systems, Inc.
	 	Delaware
	 	Yes
	2.

	 	Trim Systems Operating Corp.
	 	Delaware	 	 
	3.

	 	Trim Systems LLC
	 	Delaware
	 	Yes
	4.

	 	Tempress, Inc.
	 	Washington
	 	Yes
	5.

	 	CVG International Holdings Limited
	 	Barbados	 	 
	6.

	 	CVG (Shanghai), Co. LTD.
	 	China	 	 
	7.

	 	CVS Holdings Limited
	 	United Kingdom
	 	Yes
	8.

	 	Commercial Vehicle Systems Limited
	 	United Kingdom
	 	Yes
	9.

	 	Bostrom Limited
	 	United Kingdom
	 	Yes
	10.

	 	Bostrom Investments Limited
	 	United Kingdom	 	 
	11.

	 	KAB Seating LLC
	 	United Kingdom	 	 
	12.

	 	Bostrom International Limited
	 	United Kingdom
	 	Yes
	13.

	 	KAB Seating, AB
	 	Sweden	 	 
	14.

	 	KAB Seating, Pty
	 	Australia	 	 
	15.

	 	KAB Seating, S.A.
	 	Belgium	 	 
	16.

	 	National Seating Company
	 	Delaware
	 	Yes
	17.

	 	KAB Seating Limited
	 	United Kingdom
	 	Yes
	18.

	 	A. Stokes Pressings Limited
	 	United Kingdom	 	 
	19.

	 	Wilton & Co. Pressings Limited
	 	United Kingdom	 	 
	20.

	 	Bostrom Specialist Engineering Limited
	 	United Kingdom	 	 
	21.

	 	Winston Cable Limited
	 	United Kingdom	 	 
	22.

	 	JMH Limited
	 	United Kingdom	 	 
	23.

	 	KAB Tooling Limited
	 	United Kingdom	 	 
	24.

	 	Bostrom Europe
	 	United Kingdom	 	 
	25.

	 	The C&P Jig & Tool Limited
	 	United Kingdom	 	 
	26.

	 	BB Seating Limited
	 	United Kingdom	 	 
	27.

	 	Palmer & Shelley Limited
	 	United Kingdom	 	 
	28.

	 	AJW Holdings Limited
	 	United Kingdom	 	 
	29.

	 	KAB Industries Limited
	 	United Kingdom	 	 
	30.

	 	Corvus Suspension Products Limited
	 	United Kingdom	 	 
	31.

	 	KAB Pressings Limited
	 	United Kingdom	 	 
	32

	 	KAB Components Limited
	 	United Kingdom	 	 
	33.

	 	AJ Williams Small Pressings Limited
	 	United Kingdom	 	 
	34.

	 	Bostrom Vehicle Components Limited
	 	United Kingdom	 	 
	35.

	 	Inbark Limited
	 	United Kingdom	 	 
	36.

	 	KAB Engineering Limited
	 	United Kingdom	 	 
	37.

	 	CVS Holdings, Inc.
	 	Delaware
	 	Yes
	38.

	 	Commercial Vehicle Systems,
Inc.
	 	Delaware
	 	Yes

 

 

SCHEDULE D-1

Baird Capital Partners III L.P.

Baird Capital Partners II L.P.

BCP III Affiliates Fund L.P.

BCP III Special Affiliates L.P.

BCP II Affiliates Fund L.P.

Norwest Equity Partners VII L.P.

Kenneth W. Hager

David J. Huls

S.A. Johnson

Daniel F. Moorse

Carl E. Nelson

Judith A. Vijums

Marni L. Nagy

Ronald A. Johnson

Randolph Street Partners II

Robert R. Hibbs

Mary-Louise R. Johnson Trust

Michael Szczepanski

Hidden Creek Industries

 

 

SCHEDULE D-2

Kenneth W. Hager

David J. Huls

S.A. Johnson

Daniel F. Moorse

Carl E. Nelson

Judith A. Vijums

Marni L. Nagy

Ronald A. Johnson

Randolph Street Partners II

Robert R. Hibbs

Mary-Louise R. Johnson Trust

Michael Szczepanski

Hidden Creek Industries

 

 

SCHEDULE D-3

Onex American Holdings II LLC

Bostrom Executive Investco LLC

CVS Executive Investco LLC

Onex DHC LLC

Trim Systems Executive Investco LLC

Trim Systems Executive Investco II LLC

Bostrom Partners LP

1170821 Ontario Inc.

1170809 Ontario Inc.

1170812 Ontario Inc.

Kyzalea Company

1170819 Ontario Inc.

1170698 Ontario Inc.

1301449 Ontario Inc.

1352536 Ontario Inc.

1376653 Ontario Inc.

1352537 Ontario Inc.

Tim Duncanson

3-G Investments Limited

Serge Gouin

Brian King

J.W.E. Mingo

Robert Prichard

1299039 Ontario Inc.

2668921 Manitoba Ltd

Onex Advisor III LLC

CVS Partners, LP

3062601 Nova Scotia Company

AMON Canadian Investments Ltd.

MHON Canadian Investments Ltd.

Baird Capital Partners III L.P.

Baird Capital Partners II L.P.

BCP III Affiliates Fund L.P.

BCP III Special Affiliates L.P.

BCP II Affiliates Fund L.P.

Norwest Equity Partners VII L.P.

 

 

EXHIBIT A

OPINION OF KIRKLAND & ELLIS LLP

 

 

EXHIBIT B

OPINION OF KIRKLAND & ELLIS LLP

 

 

EXHIBIT C

OPINION OF KAYE SCHOLER LLP

 

 

EXHIBIT D

OPINION OF DRINKER BIDDLE & REATH LLP

 

 

EXHIBIT E

CERTIFICATE OF CHIEF FINANCIAL OFFICER

[     ], 2004

Credit Suisse First Boston LLC

Eleven Madison Avenue

New York, NY 10010

Dear Sirs:

     In 2002, Trim Systems Operating Corp., Commercial Vehicle Systems
Holdings, Inc. and CVS Holdings Ltd. (the “Constituent Entities”) dismissed
their independent auditors, Arthur Andersen LLP (“Andersen”) and engaged the
services of Deloitte & Touche LLP (“Deloitte”) as their new independent
auditors for the fiscal year ending December 31, 2002. The boards of directors
and audit committees of each of the Constituent Entities authorized the
dismissal of Andersen and the engagement of Deloitte. Given this change in
independent public accountants, you have asked me to provide you with certain
information as of the date hereof in connection with the offering (the
“Offering”) of Common Stock, par value $0.01 per share (the “Securities”) of
the Company. To that end, in my capacity as Chief Financial Officer of the
Company, I do hereby certify to the best of my knowledge based upon a review of
the financial records and schedules of the Company made by me or members of my
staff that:

     Nothing has come to my attention that would cause me to believe that the
consolidated balance sheets of the Company as of December 31, 1999 and 2000 and
the related financial data included in the registration statement (No.
333-115708) on Form S-1 filed by the Company under the Securities Act of 1933
(the “Registration Statement”) do not fairly represent the financial position
of the Company and its subsidiaries in all material respects in conformity with
accounting principles generally accepted in the United States.

     I, or members of my staff, have read the items marked on the attached
copies of selected pages of the Registration Statement and have performed the
following procedures, which were applied as indicated by the letters set forth
below:

          A. Agreed to or derived from the Constituent Entities’ separate financial
statements (which were individually audited by Andersen) which have been
combined as a result of their merger, after giving effect to the required
generally accepted accounting principles adjustments as a result of the merger
of the Constituent Entities.

          B. Proved the arithmetic accuracy based on amounts in or derived from the
Constituent Entities’ separate financial statements (which were individually
audited by Andersen) which have been combined as a result of their merger,
after giving effect to the required generally accepted accounting principles
adjustments as a result of the merger of the Constituent Entities.

     This letter is being provided solely for the information of Credit Suisse
First Boston LLC, as representative of the underwriters, to assist the
underwriters in conducting and documenting their investigation of the affairs
of the Company in connection with the Offering, and this letter is not to be
used, circulated, quoted or otherwise referred to for any purpose.

 

 

     To evidence my certification as an officer of the Company of the foregoing
information, I have set my hand to this letter on the date first written above.

	 	 	 	 	 
	 	Very truly yours,

COMMERCIAL VEHICLE GROUP, INC.,

 	 
	 	    by

	
 	 
	 	 	Name:  	Chad M. Utrup 	 
	 	 	Title:  	Chief Financial Officer 	 

 

 

	 	 	 	 	 

EXHIBIT F

FORM OF LOCK-UP AGREEMENT

Commercial Vehicle Group, Inc.

6530 West Campus Way

New Albany, Ohio 43054

Credit Suisse First Boston LLC

Lehman Brothers Inc.

Robert W. Baird & Co. Incorporated

(collectively, the “Underwriters”)

	c/o 	 	Credit Suisse First Boston LLC

Eleven Madison Avenue

New York, NY 10010-3629

     Dear Sirs:

     As an inducement to the Underwriters to execute the Underwriting Agreement
(the “Underwriting Agreement”), pursuant to which an offering (the “Offering”)
will be made that is intended to result in the establishment of a public market
for the common stock, par value $0.01 per share (the “Securities”) of
Commercial Vehicle Group, Inc., and any successor (by merger or otherwise)
thereto (the “Company”), the undersigned hereby agrees that during the period
specified in the following paragraph (the “Lock-Up Period”), the undersigned
will not offer, sell, contract to sell, pledge or otherwise dispose of,
directly or indirectly, any shares of Securities or securities convertible into
or exchangeable or exercisable for any shares of Securities, enter into a
transaction which would have the same effect, or enter into any swap, hedge or
other arrangement that transfers, in whole or in part, any of the economic
consequences of ownership of the Securities, whether any such aforementioned
transaction is to be settled by delivery of the Securities or such other
securities, in cash or otherwise, or publicly disclose the intention to make
any such offer, sale, pledge or disposition, or to enter into any such
transaction, swap, hedge or other arrangement, without, in each case, the prior
written consent of Credit Suisse First Boston LLC (“CSFB”). In addition, the
undersigned agrees that, without the prior written consent of CSFB, it will
not, during the Lock-Up Period, make any demand for, or exercise any right with
respect to, the registration of any Securities or any security convertible into
or exercisable or exchangeable for the Securities except in connection with the
Offering.

     The initial Lock-Up Period will commence on the date of this Lock-Up
Agreement and continue for 180 days after the public offering date set forth on
the final prospectus used to sell the Securities (the “Public Offering Date”)
pursuant to the Underwriting Agreement; provided, however, that if (1) during
the last 17 days of the initial Lock-Up Period, the Company releases earnings
results or material news or a material event relating to the Company occurs
(and, in the case of material news or material event, CSFB gives the notice
thereof to [     ] or (2) prior to the expiration of the initial
Lock-Up Period, the Company announces that it will release earnings results
during the 16-day period beginning on the last day of the initial Lock-Up
Period, then in each case the Lock-Up Period will be extended until the
expiration of the 18-day period beginning on the date of release of the
earnings results (which in the case of clause (2) must occur prior to the

 

 

expiration of such 16-day period) or the occurrence of the material news
or material event, as applicable, unless CSFB waives, in writing, such
extension.

     Any Securities received upon exercise of options granted to the
undersigned will also be subject to this Agreement. Any Securities acquired by
the undersigned in the open market or in the issuer directed share program, and
any Securities sold in the Offering pursuant to the Underwriting Agreement,
will not be subject to this Agreement. A transfer of Securities (or other
transaction of the types restricted in the first paragraph of this letter) to a
family member, trust, affiliate of the undersigned, or a director, officer or
employee of the undersigned or of an affiliate of the undersigned may be made,
provided the transferee agrees to be bound in writing by the terms of this
Agreement. In addition, the undersigned may transfer Securities or securities
convertible into or exchangeable or exercisable for Securities pursuant to a
sale of 100% of the outstanding Securities (including, without limitation, in
connection with a tender offer for such Securities or by way of merger of the
Company with another person) to a third party or group of third parties that
are not affiliates of the Company (and may make offers or enter into contracts
with respect to such a transfer), provided that unless the third party or group
is acquiring 100% of the outstanding Securities of the Company in a single
transaction or concurrent transactions, the third party or group of third
parties agrees in writing to be bound by the restrictions set forth herein
until such time as such third party or group of third parties has acquired 100%
of the outstanding Securities of the Company.

     In furtherance of the foregoing, the Company and its transfer agent and
registrar are hereby authorized to decline to make any transfer of shares of
Securities if such transfer would constitute a violation or breach of this
Agreement.

     This Agreement shall be binding on the undersigned and the successors,
heirs, personal representatives and assigns of the undersigned. This Agreement
shall lapse and become null and void (a) if the Underwriting Agreement or the
obligation of the Underwriters to purchase Securities thereunder is terminated,
(b) if the registration statement filed with the SEC in respect of the Offering
is withdrawn, (c) if the closing of the Offering pursuant to the Underwriting
Agreement shall not have occurred on or before October 31, 2004 or (d) if,
prior to the undersigned’s execution and delivery of the Underwriting
Agreement, the undersigned notifies CSFB in writing at its address set forth
above (Attention: Transactions Advisory Group) that it does not then intend to
pursue an offering of the Securities through CSFB as an underwriter. This
Agreement shall be governed by, and construed in accordance with, the laws of
the State of New York.

	 	 	 	 	 
	 	Very truly yours,

 	 
	 	By:  	 	 	 
	 	
	 
	 	Name:exv10w3

 

Exhibit 10.3

JOINDER TO REGISTRATION AGREEMENT

     THIS JOINDER TO REGISTRATION AGREEMENT (this “Joinder”) is executed as of
                       , 2004, by and among Commercial Vehicle Group, Inc., a Delaware
corporation (the “Company”), and the Persons listed on Schedule A attached
hereto (the “New Investors”).

     WHEREAS, the Company, Onex Corporation, J2R Partners VII and certain other
stockholders of the Company are party to that certain Registration Agreement,
dated as of October 5, 2000, as amended (the “Registration Agreement”).
Capitalized terms used but not defined herein have the meaning given to them in
the Registration Agreement.

     WHEREAS, the New Investors have acquired shares or rights to acquire
shares in the Company, in connection with, among other things, that certain
Agreement and Plan of Merger, dated even herewith, by and between the Company,
Trim Merger Co., and Trim Systems, Inc.

     WHEREAS, the Company desires to provide the New Investors rights under the
Registration Agreement as set forth herein.

     NOW, THEREFORE, the parties hereto agree as follows:

     1. Joinder. The parties hereto agree that, by and upon execution of this
Joinder, each New Investor shall be a party to the Registration Agreement, (ii)
shall be an “Investor” (as such term is defined in the Registration Agreement)
and (iii) shall be entitled to the rights and benefits and subject to the
duties and obligations of an Investor thereunder, as fully as if such New
Investor had been an original signatory thereto in such capacity.

     2. Continuing Effect. Other than as modified in accordance with the
foregoing provisions, the remaining terms of the Registration Agreement remain
in full force and effect.

     3. Counterparts. This Joinder may be executed in separate counterparts
each of which shall be an original and all of which taken together shall
constitute one and the same agreement.

     4. Governing Law. All questions concerning the construction, validity and
interpretation of this Joinder shall be governed by and construed in accordance
with the internal laws, and not the law of conflicts, of Delaware.

     5. Descriptive Headings. The descriptive headings of this Agreement are
inserted for convenience only and do not constitute a part of this Agreement.

* * * * *

 

 

     IN WITNESS WHEREOF, this Joinder has been entered into as of the date
first above written.

	 	 	 	 	 
	 	 	BOSTROM HOLDING, INC.
	 
	 	 	 	 
	

	 	By:
	 	                                                                            
	

	 	Name:
	 	                                                                            
	

	 	Its:
	 	                                                                            
	 
	 	 	 	 
	 	 	ONEX DHC LLC
	 
	 	 	 	 
	

	 	By:
	 	                                                                            
	

	 	Name:
	 	                                                                            
	

	 	Its:
	 	                                                                            
	 
	 	 	 	 
	 	 	TRIM SYSTEMS EXECUTIVE INVESTCO LLC
	 
	 	 	 	 
	

	 	By:
	 	                                                                            
	

	 	Name:
	 	                                                                            
	

	 	Its:
	 	                                                                            
	 
	 	 	 	 
	 	 	TRIM SYSTEMS EXECUTIVE INVESTCO II LLC
	 
	 	 	 	 
	

	 	By:
	 	                                                                            
	

	 	Name:
	 	                                                                            
	

	 	Its:
	 	                                                                            

 

 

[Continuation of signature page to Joinder to Registration Agreement]

	 	 	 	 	 
	 	 	ASC INCORPORATED
	 
	 	 	 	 
	

	 	By:
	 	                                                                            
	

	 	Name:
	 	                                                                            
	

	 	Its:
	 	                                                                            
	 
	 	 	 	 
	 	 	AMON CANADIAN INVESTMENTS, LTD.
	 
	 	 	 	 
	

	 	By:
	 	                                                                            
	

	 	Name:
	 	                                                                            
	

	 	Its:
	 	                                                                            
	 
	 	 	 	 
	 	 	MHON CANADIAN INVESTMENTS, LTD
	 
	 	 	 	 
	

	 	By:
	 	                                                                            
	

	 	Name:
	 	                                                                            
	

	 	Its:
	 	                                                                            
	 
	 	 	 	 
	 	 	J2R PARTNERS II
	 
	 	 	 	 
	

	 	By:
	 	                                                                            
	

	 	Name:
	 	                                                                            
	

	 	Its:
	 	                                                                            
	 
	 	 	 	 
	 	 	

	 	 	Marni L. Johnson
	 
	 	 	 	 
	 	 	

	 	 	Ronald A. Johnson
	 
	 	 	 	 
	 	 	

	 	 	Robert R. Hibbs

 

 

[Continuation of signature page to Joinder to Registration Agreement]

	 	 	 	 	 
	 	 	

	 	 	Eric L. Hupp
	 
	 	 	 	 
	 	 	

	 	 	Michael Szczepanski
	 
	 	 	 	 
	 	 	

	 	 	Cleve S. Blunt
	 
	 	 	 	 
	 	 	

	 	 	Jim Lindsey
	 
	 	 	 	 
	 	 	

	 	 	Frank Lolli
	 
	 	 	 	 
	 	 	

	 	 	Greg Stepanek
	 
	 	 	 	 
	 	 	

	 	 	Chad Utrup
	 
	 	 	 	 
	 	 	

	 	 	Richard Steele
	 
	 	 	 	 
	 	 	

	 	 	Robert C. Chastain
	 
	 	 	 	 
	 	 	

	 	 	Robert Averitt
	 
	 	 	 	 
	 	 	

	 	 	Mervin Dunn
	 
	 	 	 	 
	 	 	

	 	 	Douglas P. Liehr
	 
	 	 	 	 
	 	 	

	 	 	Kevin Richards
	 
	 	 	 	 
	 	 	

	 	 	James Williams
	 
	 	 	 	 
	 	 	

	 	 	Clint Arney
	 
	 	 	 	 
	 	 	

	 	 	William G. Szuch

 

 

Schedule A

ONEX DHC LLC

TRIM SYSTEMS EXECUTIVE INVESTCO LLC

TRIM SYSTEMS EXECUTIVE INVESTCO II LLC

AMON CANADIAN INVESTMENTS, LTD.

MHON CANADIAN INVESTMENTS, LTD

J2R PARTNERS II

ASC INCORPORATED

Marni L. Johnson

Ronald A. Johnson

Robert R. Hibbs

Eric L. Hupp

Michael Szczepanski

Cleve S. Blunt

Jim Lindsey

Frank Lolli

Greg Stepanek

Chad Utrup

Richard Steele

Robert C. Chastain

Robert Averitt

Mervin Dunn

Douglas P. Liehr

Kevin Richards

James Williams

Clint Arney

William G. Szuch

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00071-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00071-of-00352.parquet"}]]